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ABSTRACT 
In order to respond to environmental stimuli, cells utilize an interconnected 
network of molecules. This work describes the application of next-generation 
sequencing data to unravel these networks, with a focus on ChiP-seq for the 
identification of transcriptional regulatory networks. A ChiP-seq pipeline 
designed to analyze high coverage sequence data is described. This pipeline 
utilizes a simple model of background coverage, along with filtering steps and 
blind deconvolution to identify sites accurately and at high resolution. 
Comparisons to other peak calling algorithms on ChiP-seq experiments for 
previously characterized regulons show that this pipeline is the only method that 
identifies all previously identified targets for two previously characterized 
transcription factors in Mycobacterium tuberculosis, DosR and KstR. 
This pipeline has been applied to ChiP-seq data in order to identify a genome 
scale regulatory network of the human pathogen Mycobacterium tuberculosis This 
network was identified using an inducible promoter system to induce the 
expression of over half of the transcription factors of Mycobacterium tuberculosis. 
This network is highly interconnected, containing more binding sites than 
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initially expected for each transcription factor assayed. A subnetwork involving 
hypoxia and lipid metabolism genes is described using molecular profiling data 
to support these findings. The pipeline was also applied for the identification of a 
regulatory subnetwork of clock-regulated light-induced genes in Neurospora 
crassa. This network is also highly interconnected, and shows complex regulatory 
feedback onto the core clock genes. 
Finally, the use of ChiP-seq and microarray data to predict a small RNA (sRNA) 
regulatory network in Mycobacterium tuberculosis is described. sRNA-gene 
regulations were predicted using network inference and target prediction 
algorithms, and the transcriptional regulatory network was used to filter 
predicted interactions that could be described by transcriptional regulation. 
Known sRNA targets of Mtb transcription factors are identified, and small RNAs 
that may play a role in the hypoxic response are identified. Predicted targets of 
these sRNAs are consistent with the known function of many of the regulators of 
the sRNA. Together, these studies have produced resources that can be applied 
to better understand not only the biology of these organisms, but also the general 
nature of regulatory networks. 
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1 Introduction 
1.1 Regulation of Cellular Processes 
In order to adapt to changing environments, organisms employ a highly 
interconnected regulatory network of interacting components. These components 
include nucleic acids and proteins encoded for by the genome of the cell, as well 
as metabolites such as lipids, amino acids, both produced by enzymatic reactions 
carried out within the cell and taken in from the environment. These moieties act 
in concert to regulate the uptake, synthesis, and metabolism of compounds 
required by the cell to function. A better understanding of how these networks 
are organized can allow researchers to both understand how organisms function, 
and provide a foundation for the design of novel biological constructs. 
Network-based approaches have helped both understand the behavior of 
specific organisms, and have also helped better our knowledge about basic 
biological phenomena[1-8]. From a mechanistic point of view, understanding of 
how biological networks are constructed has provided a better understanding of 
cell dynamics[8-ll]. Networks have also lead to a better understanding of the 
interactions between microbes and host organisms[12, 13]. For example, network 
biology approaches have led to a better understanding of the mechanisms of 
action of antibiotics[14, 15]. A network approach has been applied to the study of 
cancer[16], and has also been used in a the context of the human microbiome in 
the study of obesity and inflammatory bowel disease[17]. 
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1.2 Regulatory Mechanisms Employed by the Cell 
One of the earliest stages where regulation is performed within the cell is 
in the conversion of DNA to messenger RNA by the RNA Polymerase. In 
prokaryotes, RNA Polymerase binds to one of several proteins known as sigma 
factors to form a holoenzyme required for the initiation of transcription[ IS]. In 
any given organism, there is usually a combination of primary sigma factors, 
which includes one "housekeeping" sigma factor. The housekeeping sigma factor 
controls the transcription of essential genes required for growth of the organism. 
In E. coli, this function is carried out by a 70, encoded for by the rpoD gene[19]. In 
addition, some organisms have other sigma factors which are closely related to 
the housekeeping sigma, though are not required for growth. For example, a 5 
controls the expression of stress-related genes in E. coli[20]. 
In addition to the primary sigma factors, the bacterial genome encodes for 
a variety of secondary sigma factors, which are responsible for the expression of 
sets of genes required to adapt to various stresses. The number of these 
alternative sigma depends on the variety of conditions in which the organism is 
expected to thrive[19]. This number ranges from 2 in Streptococcus pyogenes, 
which is found in the human pharynx, to 60 in Streptomyces coelicolor, a soil-
dwelling bacteria which must adapt to a variety of conditions and other 
organisms competing for resources[21]. Sigma factors which coordinate 
regulatory programs in response to hypoxia[22], oxidative[23] and temperature 
stress[24, 25], and starvation[20, 26] have been identified. These alternative sigma 
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factors can be regulated post-translationally by cognate anti-sigma factors[27, 
28]. This provides another level of control in order to adapt to varying 
conditions. In turn, proteins known as anti-anti sigma factors can reverse the 
repression by anti-sigma factors, which function by a variety of methods, from 
cell export to enzymatic modification[27]. Additionally, these sigma factors have 
been shown to act as part of an extended sigma factor network in multiple 
organisms[21, 29], which allows for adaptation to environments which present 
multiple stresses. 
In eukaryotes, transcription of genes into messenger RNA is performed by 
the RNA Polymerase II holoenzyme, while RNA Polymerase I and III transcribe 
ribosomal and small RNA sequences, respectively[30]. The regulatory sequence 
which the polymerase recognizes is known as the core promoter[31]. Whereas 
the polymerase is recruited by a single sigma factor in prokaryotic transcription, 
the basal transcriptional machinery in eukaryotes consists of a number of basal 
transcription factors[32], which work in concert to perform the transcription of a 
gene. Additionally, eukaryotic genes can code for multiple transcripts through 
the process of alternative splicing, which assembles the exons of the gene. One 
other major difference between prokaryotic and eukaryotic transcription is in the 
compartmentalization of the transcriptional machinery. In eukaryotes, 
transcription is carried out in the nucleus, while prokaryotes lack these complex 
organelles. 
While the basal transcription factors can modulate large-scale changes in 
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response to stimuli, there is a need for more nuanced transcriptional regulation 
in order to effectively respond to changes in the environment. This function is 
performed by the transcription factors encoded by the genome. Transcription 
factors are proteins that bind to promoter DNA to either recruit or block the 
sigma factor-polymerase holoenzyme, influencing the rate of transcription at a 
given promoter. The architecture of these promoters, which may include 
cooperative and competitive regulation[33], defines the regulatory program for a 
given gene. 
The classical model of prokaryotic transcriptional regulation comes from 
seminal experiments conducted by Jacob and Monod[34] and Gilbert and Miiller-
Hill[35] to study regulation of the lac operon in E. coli. The lac operon controls the 
expression of genes involved in lactose digestion, and is regulated by two 
proteins: the catabolite activator protein and the lac repressor. In the absence of 
lactose, the lac repressor binds tightly to an operator site in the promoter of the 
lac operon, blocking the polymerase from binding by steric hindrance. In the 
presence of lactose the inducer allolactose is produced. This binds to the lac 
repressor and removes its ability to bind. CAP then binds to a second operator 
site in the promoter upstream of the RNAP binding site. The polymerase 
interacts favorably with CAP, facilitating binding and thus increasing the rate of 
transcription of the lac operon. These basic mechanisms of blocking and 
recruitment of the polymerase have been the foundation of our understanding of 
transcriptional regulation, leading to the first models of transcriptional 
regulatory kinetics[36]. 
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Transcription factors can also interact with each other to provide a more 
nuanced regulatory program. We can again look to the lac operon for an 
example. Later work to study the regulation of the lac operon identified two 
additional low affinity sites for the lac repressor transcription factor. One of these 
sites was found to be roughly 100 bp upstream of the originally identified 
binding site, while the other was roughly 400bp downstream of the site, in the 
middle of the lacZ gene[37]. By studying lac repression in cells that had different 
sets of promoters it was found that, in order for the lac operon to be fully 
repressed, one of these two sites must also be bound. Given the distance between 
operator sites, this led to a model of DNA looping by the formation of lac 
repressor tetramers[38]. This has led to updated models for kinetics to 
incorporate these long-range interactions[39]. Similar long-range interactions 
have been seen in E. coli[40], as well as other bacterial organisms, including 
Bacillus subtilis[41], Salmonella enterica[42], Mycobacterium tuberculosis, and 
Klebsiella pneumoniae[43]. Long-range regulation in eukaryotes is much better 
studied than in prokaryotes. These long-range regulatory elements, known as 
enhancers, have been shown to activate transcription through the facilitation of 
the formation of DNA looping as well as recruitment of RNA Polymerase and 
general transcription factors[44]. 
Further work studying the transcriptional control of the bacteriophage 
lambda lead to a generalized thermodynamic model for the regulation of 
transcriptional regulation[45] . This model has been further extended and used to 
identify configurations of promoters that result in different Boolean logic gates 
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[33]. It was also demonstrated that the aforementioned property of DNA looping 
provided the ability for more complex regulatory circuits. The ability for 
promoters to be regulated in a combinatorial manner by a number of 
transcription factors allows for a more nuanced regulatory program, with signal 
integration being performed at promoters. 
Transcription can also be controlled by the modulation of DNA 
accessibility. In eukaryotes, DNA is wrapped around the histone octamer to 
package the DNA into nucleosomes, the basic unit of chromatin. Covalent 
modifications to these histones, including acetylation, methylation, 
phosphorylation and glycocylation[46], can modulate large-scale changes in the 
expression of genes. Combinations of these modifications work together to create 
an "epigenetic code"[47], which regulates the organization of chromatin to 
modulate the availability of DNA. Histone modifications have been found to be 
associated with enhancer sites, play a major role in cell differentiation, and are 
also associated with disease states[47]. 
While bacteria do not have the histone proteins which package the DNA 
in eukaryotes, proteins that perform similar functions have been identified in 
prokaryotes. These proteins, known as nucleoid associated proteins (NAPs), first 
identified in E. coli, can alter the large-scale structure of chromosomal DNA by 
looping, wrapping, and DNA bridging[48]. By making large-scale changes to the 
accessibility of DNA, large numbers of genes can be repressed and de-repressed. 
One of the most well studied examples of a NAP is the H-NS protein. H-NS was 
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first identified in E. coli, but similar proteins have been identified in M. 
tuberculosis[49], Pseudomonas aeruginosa, Shigella flexnari, and Vibrio cholerae[SO]. H-
NS works by bridging DNA, which allows for the modulation of nucleoid 
structure, as well as global repression of genes. In addition, CRP, first thought to 
act as a traditional transcriptional activator, has been shown to bind in hundreds 
of places on the genome, and has been shown to introduce bending at its binding 
sites[Sl] . This indicates that the line between "traditional" transcription factors 
and NAPs may be somewhat blurred. 
Noncoding regulatory RNAs have also been identified as regulatory 
mechanisms in both prokaryotes and eukaryotes. In eukaryotes, these are 
separated into long (lncRNAs) non-coding RNAs and microRNAs (miRNAs). 
lcRNAs are transcribed RNAs which do not code for proteins, and are less than 
200nt in length[52]. While these sequences were originally thought of as genetic 
"noise"[53], further analyses of these molecules have identified a regulatory 
role[54]. Potential functions of lncRNAs include regulation of chromatin 
modification, transcription, translation, as well as post-transcriptional 
modification[55]. These RNAs have also been associated with a variety of disease 
states, including neurological disorders, heart disease, and autoimmune 
diseases[S2]. Finally, lncRNAs have been found to serve as precursors to smaller 
functional RNAs[56]. In contrast, miRNAs are shorter noncoding RNAs, with an 
average length of 22 nucleotides. These small RNA sequences act through base 
pairing with target mRNA to regulate function. The first identification of 
miRNAs was in C. elegans, where a miRNA was found to control development by 
8 
repression of translation by binding to the 3' UTR[57, 58]. These small RNAs 
have been shown to play a major role in regulation, playing a role in 
development, circadian biology, and disease states. Large numbers of these 
miRNAs have been identified in the human genome as well as in the genomes of 
many model organisms[59-61]. 
In contrast regulatory RNAs in prokaryotes belong to a single class, 
known as small regulatory RNAs (sRNAs). These RNAs are either encoded 
antisense to protein coding regions or within intergenic regions. sRNAs are 
analogous to eukaryotic miRNAs, in that they largely operate via perfect or 
imperfect base pairing with their target mRNAs. sRNAs in the context of 
Mycobacterium tuberculosis are reviewed in detail in Chapter 5 of this work. 
1.3 Methods for the Identification of Regulatory Networks 
In order to better understand how these networks give rise to the behavior 
needed to adapt and respond to environmental stimuli, the links between the 
various molecules in the cell must be identified. This section describes a number 
of methods for the inference and identification of transcriptional regulatory 
networks, which are the focus of this work. 
1.3.1 Network Inference 
With the advent of the microarray came the ability to measure the relative 
or absolute abundance of messenger RNA at high throughput. Expression levels 
across the genome can be compared between two conditions, for example, where 
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transcription factor is perturbed (knocked out or overexpressed) or not (wild 
type strain) [62]. Transcripts that are significantly differentially expressed 
between conditions are potential direct and indirect targets of the TF. In some 
cases, direct targets contain a common DNA binding motif in their promoter 
regions, which can be found computationally. 
As more and more high throughput transcriptome data has become 
available for a number of organisms, there has been a development of network 
inference methods to utilize this data to identify potential transcription 
factor I gene interactions. Algorithms have been developed which use knockout 
data, time series data, as well as more generally using data from a variety of 
conditions[4, 63, 64]. Often, this is performed using microarray data retrieved 
from a general gene expression database such as the Gene Expression 
Omnibus[65] or ArrayExpress[66], or an organism-specific microarray database 
such as the M3D[ 67], which is a compendium of Escherichia coli microarray data 
collected under a variety of different conditions on the same platform. In a 
similar fashion to knockout experiments, a search of the potential targets for a 
consensus sequence can potentially be used to distinguish between direct and 
indirect regulation by regulatory proteins. 
1.3 .2 In vitro Site Identification Methods 
There have been a variety of in vitro methods designed to identify and 
validate potential binding sites. These include DNA footprinting, which uses a 
DNA cleavage agent to identify regions of DNA that are bound, and thus 
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protected by proteins[68]. Another method, if the putative binding sequence is 
known, is the electrophoretic mobility shift assay (EMSA)[69]. While these 
methods are not high throughput, they can be used to better map complex 
promoter architectures and determine if a protein can bind a sequence of interest. 
A method that has been used to characterize DNA binding proteins at high 
throughput is the protein binding microarray[70, 71]. These microarrays consist 
of double stranded DNA consisting of all possible oligomers of a given length. 
An epitope tagged transcription factor is bound to these probes, and labeled with 
a fluorescent antibody. The amount of fluorescence signal correlates with the 
binding affinity of the sequence probe for the protein. From the set of probes that 
are bound, a binding motif can be identified for the protein. While this method 
does not identify locations on the genome bound by the proteins, a motif search 
can be performed to identify potential targets. 
1.4 In vivo Binding Identification by Chromatin Immunoprecipitation 
Finally, chromatin immunoprecipitation provides a method for the 
identification of transcription factor binding sites in vivo. Chromatin 
Immunoprecipitation (ChiP) is one of the most widely used tools for 
investigating the interaction of DNA binding proteins with their target DNA 
sequences in vivo[72]. In ChiP, cells are treated with formaldehyde to crosslink 
DNA-bound proteins to DNA, and sonication is performed to shear the DNA 
into fragments. This is summarized in Figure 1. An antibody specific to the 
protein of interest is used to pull down the protein-DNA complexes containing 
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the protein of interest. The crosslinking is then reversed, and the DNA is mapped 
to the genome of interest to identify positions of binding[73]. Historically, this 
was performed first for localized sites, using polymerase chain reaction (PCR), 
then globally by using DNA microarrays (ChlP-chip)[74], and later by 
sequencing of short reads[75]. 
1.5 Project Overview 
While the full force of -omics measurements has been applied to human 
data through the ENCODE project, as well as Drosophila and C. elegans[76] 
through the MODENCODE project, we have not seen such a coordinated effort 
in single celled organisms. Recently, the National Institute of Allergies and 
Infectious diseases at the National Institute of Health set forth to take this 
systems level approach[77] to human pathogens. Additionally, other model 
organism communities have started to take a systems level approach to the 
organisms that they study. One such project is the Neurospora Fungal Genomics 
project[78]. This dissertation describes work performed in support of a larger 
scale Tuberculosis Systems Biology Project as well as the Neurospora Fungal 
Genomics project, with a focus on the use of ChiP-seq to identify transcriptional 
regulatory networks. 
This project is split into four major aims, each of which is described in one 
the subsequent chapters. Chapter 1 outlines the development of a pipeline and 
software tool for the identification of transcription factor binding sites from 
ChiP-seq data. Chapter 2 describes the use of this tool, along with other "-omics" 
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data to reconstruct a large portion of the gene regulatory network in 
Mycobacterium tuberculosis, an important human pathogen. Chapter 3 describes 
the application of these methods to Neurospora crassa, a long-standing model 
organism with many genomic features seen in more complex eukaryotic 
organisms. Finally, Chapter 4 describes the extension of the Mycobacterium 
tuberculosis regulatory network to include small regulatory RNAs, which have 
been shown to be a major contributor to the regulatory program of the cell. The 
final chapter summarizes the findings described in this work, and suggests 
potential experiments to follow up on these findings. 
13 
2 A Pipeline for the Identification of Transcription Factor Binding Sites from 
ChiP-seq 
2.1 ChiP-seq 
Recent advances in sequencing technology have allowed for the high 
throughput sequencing of DNA fragments produced by immunoprecipitation. 
This method, known as chromatin immunoprecipitation followed by sequencing 
(ChiP-seq) was one of the earliest uses of the current generation of sequencing 
technologies[75]. The use of sequencing for assaying the DNA fragments 
resulting from ChiP experiments has shown to have many advantages over the 
use of microarrays[79]. Sequencing experiments require a smaller amount of 
DNA, and provide whole genome coverage without having to select regions of 
the genome to assay in advance[73]. While there can be some issues with GC-bias 
in sequencing experiments[80], the analysis of microarray data must take into 
account cross-hybridization of probes[81], which can cause greater issues with 
analysis. Also, ChiP-seq experiments have the capacity for single nucleotide 
resolution of binding sites[82]. Finally, ChiP-seq experiments in eukaryotes with 
very large genomes tend to be cheaper than ChiP-chip experiments, due to the 
need for multiple tiling microarrays to cover the genome[83]. 
CTAGCTAGCCATATCCATGA 
ATCGTAAGCTTAGACGATACC 
ATCGTAAGCTTAGACGATACC 
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Crosslink proteins to DNA 
with formaldehyde; Shear DNA 
Perform a pulldown 
with an antibody against the 
protein of interest 
Reverse crosslink and sequence. 
Regions of the genome bound will 
be represented by peaks in coverage 
Figure 1. The ChiP-seq workflow 
The use of ChiP-seq has provided a great deal of insight into the 
landscape of transcription factor binding in eukaryotic organisms. Initial studies 
of transcription factor binding focused on the identification of transcription 
factors in proximal promoter regions. However, the ENCODE pilot project[84] 
has shown that binding is not as confined to promoter regions as initially 
hypothesized -transcription factors were shown to bind in various places along 
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the genome at high and low affinity, with less than 10% of the transcription 
factors preferring to bind in proximal promoter regions. This phenomenon was 
also seen in other mammalian organisms[85], Drosophila melanogaster[86], C. 
elegans[87] and yeast[88]. This has resulted in a reexamination of the mechanisms 
of transcriptional regulation, with evidence showing that transcriptional 
regulation is described as more of an analog process than digital, which had been 
the prevailing model[88]. 
2.2 Computational Analysis of ChiP-seq Data 
While there are advantages of ChiP-seq over ChiP-chip, ChiP-seq places a 
greater burden on the data management and analysis tools when compared to 
ChiP-chip. The storage costs of ChiP-seq data are much higher, and the 
identification of peaks from ChiP-seq data is more computationally intensive 
than comparing microarray intensities. There have been a variety of file formats 
designed to store the short reads produced by short read sequencing 
experiments[89] and many peak calling algorithms for identifying enriched 
regions from ChiP-seq data. These have been extensively reviewed and 
benchmarked[90-92]. 
There have been a variety of approaches taken in the analysis of ChiP-seq 
data. As described in [93], these approaches largely consist of three main steps. In 
the first, a profile of sequencing tags is generated across the genome. Secondly, a 
background model is built for comparison, and the ChiP-seq experiment is 
scored against this background. Finally, these calls are post-processed- this may 
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include filtering of false positive calls, identifying areas of highest enrichment 
within regions, and ranking peak candidates. 
In the first step, a distribution of sequencing tags resulting from the ChiP-
sequencing experiment is created. Some algorithms take a windowing approach, 
where the number of reads within adjacent[94, 95] or overlapping[96] windows 
are used to calculate coverage, while others use the coverage at each position, 
either calculated directly from the coverage data[96, 97] or from a smoothing 
function[98, 99]. Some of the available algorithms take the shift observed 
between the forward and reverse in enriched regions into account during this 
step, shifting one or both of the coverage profiles to create a combined coverage 
profile, while others treat the lanes separately, creating two coverage profiles 
which are scored separately. 
Next, a background model is chosen in order to score the 
immunoprecipitation experiment. In some cases, this background model is 
calculated across the entire genome, while others split the genome into multiple 
segments in order to deal with potential biases in coverage in different regions of 
the genome[96, 100]. Additionally, some peak calling algorithms take a control 
sample into account at this point[96, 99, 101]. The types of background DNA 
most often utilized are mock-immunoprecipitation DNA (DNA obtained from 
immunoprecipitation without antibodies), DNA from nonspecific 
immunoprecipitation (immunoprecipitation performed with an antibody not 
known to participate in DNA interactions), and input DNA (DNA removed prior 
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to immunoprecipitation), all of which correct for different artifacts. While there is 
no consensus on the type of control which is most appropriate[73], input DNA is 
the most widely used control. It has been shown that regions of transcription 
factor binding are often slightly enriched in input control samples, likely due to 
the availability of DNA in those regions due to the local structure of 
chromatin[lOO]. Ideally, a peak-calling tool would be able to take multiple 
background samples into account. 
Each of the available peak callers filters candidate peaks different! y based 
on the previous steps performed. For instance callers that have not yet taken into 
account the shift between the forward and reverse strand will filter those peaks 
that do not exhibit this signature shape. Some peak calling algorithms will 
alternate the background and immunoprecipitation sample to calculate a false 
discovery rate (FDR) for each peak. Peak callers that do not use a background 
sample in the creation of the background model may compare the ratio of the 
normalized coverage within each enriched region with a control sample. Many of 
these enriched regions may also contain multiple binding sites. Approaches such 
as blind deconvolution[82] or the use of sequence information[92, 102, 103] can 
be applied to identify multiple peaks located within the enriched regions 
identified by peak callers. There have also been packages developed to support 
the annotation of peaks identified by ChiP-seq analyses[104] . 
While there have been a number of peak calling algorithms written, many 
of these have been developed in support of research performed using human 
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and other large eukaryotic genomes. In fact, some of the available algorithms are 
only designed to analyze human data. Additionally, it has been shown that, for 
some of these algorithms, parameters must be changed to get the best 
performance on ChiP-seq data from different transcription factors[91]. This 
chapter describes a pipeline for the identification of enriched regions, binding 
sites, and potentially regulated genes from high coverage ChiP-seq data, 
developed to support high throughput analysis of ChiP-seq data in the pathogen 
Mycobacterium tuberculosis and the fungal model organism Neurospora crassa. 
2.3 SPAT: The Simple Peak calling and Annotation Tool 
We have named this pipeline SPAT (The Simple Peak calling and 
Annotation Tool), a pipeline for the identification of enriched regions, peaks, and 
potential transcription factor-gene links from ChiP-seq data. The SPAT pipeline 
is described in Figure 2, and each piece of the pipeline is described in detail 
below. The SPAT utility is written in Python, though some of the numerical 
analyses are performed in MATLAB. For these, the MATLAB code is compiled 
and run from the Python wrapper using the MATLAB Compiler Runtime. 
2.3 .1 Calculation of Coverage Along the Genome 
The first step of the pipeline is to calculate the sequencing coverage along 
the genome. SPAT users the pysam[l05] Python library to calculate the coverage 
along the forward and reverse strands, and produces a delimited file containing 
the coverage at each position along the genome. The coverage data is used as 
input to the rest of the pipeline. 
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Figure 2. The SPAT Pipeline. First, coverage is calculated from the aligned genome 
reads. Next, a log-normal distribution is fit and contiguous regions of enrichment 
along the genome are identified. These are filtered to remove those that do not exhibit 
the characteristic shift seen in ChiP-seq and regions enriched in control lanes. Finally, 
blind deconvolution is used to identify individual binding sites within regions, and 
potential targets are assigned. 
2.3 .2 A Lognormal Model for ChiP-seq 
ChiP-sequencing coverage exhibits a left-skewed distribution, with a long 
tail representing regions of higher enrichment along the genome. These higher 
coverage regions may be due to enrichment caused by the binding of a 
transcription factor, the binding of a protein that forms a complex with the 
transcription factor, difference of accessibility of the DNA among regions on the 
20 
genome[lOO], copy number variation[106, 107], and the mappability of a given 
sequence for the tag size chosen for sequencing[lOO]. While complex models for 
ChiP-seq data have been developed[108], the approach described in this chapter 
is a simpler one. 
A lognormal model of sequencing coverage along the genome was used in 
order to identify enriched regions of transcription factor binding. The lognormal 
fit was chosen from a number of right-tailed distributions- others tested 
included the generalized extreme value distribution, negative binomial, and 
Poisson distribution- based on the quality of fit. For a given ChiP-sequencing 
experiment, positions of the genome with coverage greater then a given 
threshold (relative to mean coverage in order to correct for variances in sequence 
depth) were removed in order to avoid fitting outliers. This is similar to the 
approach used by the PeakSeq[lOO] algorithm. Using the remaining positions, a 
lognormal distribution was fit using maximum likelihood estimation. The 
lognormal distribution is defined by the probability density function (PDF) 
1 (In x- /1) 2 
---e za-2 
x.../2rra 2 
Here, J..l and cr are the mean and standard deviation of the natural 
logarithm of the random variable, respectively. The maximum likelihood 
estimation of J..l is calculated as 
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Here, xk is the total coverage at position kin the genome and n is the number of 
points used for fitting. The maximum likelihood estimation of cr is defined as 
n 
The resulting distribution is then used to score the coverage for a given 
ChiP-seq experiment. Genome positions are considered enriched if the one-tailed 
probability for the coverage at that position is less than a specified p-value cutoff. 
Because transcription factor binding is expected to result in contiguous regions of 
enrichment, enriched regions of the genome of length greater than a predefined 
length cutoff can be used for downstream analyses. This is dependent on the 
length of the sequenced DNA fragments 
2.3 .3 Removal of Artifacts 
Binding of classical transcription factors (i.e., not histones or other 
nonspecific DNA binding proteins) is known to exhibit a signature shape, 
characterized by a peak along the forward strand, followed by a corresponding 
peak on the reverse strand. This is due to the fact that each fragment bound by 
the transcription factor is sequenced from either the 5' or 3' end, resulting in a 
bias corresponding to the fragment length between peaks. Regions that did not 
exhibit this signature shape were removed from further analysis using a cross-
correlation filter. Cross-correlation is a measure of similarity between a two 
signals as a function of a shift applied to one of them. The cross-correlation 
function, cis calculated for a given region as 
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L 
c[n] = L f[m]r[n + m] 
n=-L 
Here, f and r are the coverage in the forward and reverse strands in the 
region, and L is the length of the region. The shift between f and r is defined as 
the value of n that maximizes the function. Region calling and cross-correlation 
are performed in MATLAB, utilizing the Statistics Toolbox. 
2.3.4 Comparison to Control Lanes 
As described above, many ChiP-seq experiments are performed along 
with a corresponding control or set of controls. SPAT allows the user to calculate 
the ratio of coverage, normalized to the mean coverage, in the 
immunoprecipitation experiment to any number of control lanes. A cutoff can be 
provided for each control to eliminate regions with a ratio below the cutoff from 
any further analyses. 
2.3 .5 Blind Deconvolution 
As noted above, large regions of enrichment along the genome may 
include multiple discrete binding sites for a given factor. One method that has 
been used to resolve these peaks from within a region is blind deconvolution[82, 
109]. In short, the blind deconvolution approach first fits a function to the shape 
of the most enriched regions to identify potential binding sites. Next, this 
function is used to search the remaining regions for possible binding sites. From 
these peaks, MEME[llO, 111] is then used to identify a potential consensus 
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sequence bound by the transcription factor. Next, FIM0[112] is used to find 
instances of the motif within each of the enriched regions. Finally, a second 
round of deconvolution is performed, using the motif centers to constrain the 
location of peaks. Peaks that have evidence by both sequence and coverage are 
included in further analyses. The blind deconvolution code is written in 
MATLAB, and the SPAT pipeline acts as a wrapper for the code. In the 
implementation, the oops model is used to identify motif instances within a 50bp 
window of identified peaks, and a p-value cutoff of 0.001 is used for the FIMO 
motif search. 
2.3.6 Assignment of Target Genes From Binding Sites 
The pipeline will also assign putative targets for each given peak. Though 
long-range interactions are not straightforward and cannot be taken into account, 
genes proximal to the binding events are identified as potential regulatory 
targets of the transcription factor. First, each peak is characterized as intergenic, 
intronic, or exonic, depending on where it is located with respect to the coding 
features on the genome. For intergenic peaks, the flanking genes are included as 
potential targets, and the interaction is classified as upstream or downstream, based 
on the location of the peak relative to the genes. For genic binding sites 
(intronic/ exonic), the bound gene is included and the interaction classified as in-
gene, and the surrounding genes are included and classified in a similar manner 
to genes surrounding an intergenic region. This classification scheme is 
diagrammed in Figure 3. Alternatively, the user may simply assign the peak to 
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the nearest downstream promoter, or include all genes whose promoter is within 
a given distance of a binding site. 
lntergenic 
Downstream Upstream 
Genic 
Downstream In-gene Upstream 
Figure 3. Classification of ChiP-seq peaks. A binding site can be classified as 
intergenic or genic, while regulations can be either identified as in-gene, upstream, or 
downstream by the location of the peak relative to the target gene. Classifications 
consistent with the canonical regulatory mechanisms are shown in green. 
2.4 Comparison to Other Peak Calling Algorithms 
In order to compare the performance of SPAT to other peak calling 
algorithms, we compared the performance of our pipeline against QuEST, 
MACS, HOMER, and PeakRanger for a ChiP-seq experiment for the E. coli 
transcription factor Nac. Binding sites were compared to the set of binding sites 
for Nac from EcoCyc[113]. Of the methods tested, our pipeline was the only 
method to identify all of the known binding sites (Figure 4). This was also seen in 
experiments for transcription factors in Mycobacterium tuberculosis, which are 
discussed in detail in Chapter 3. In addition, while our pipeline identifies a 
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greater number of peaks than the other methods, the total number of nucleotides 
covered by the binding sites was lower, indicating greater resolution. 
12 
9 
6 
3 
0 
EcoCyc SPAT MAGS QuEST HOMER 
Figure 4. SPAT Performance on the nac E. coli binding sites found in EcoCyc 
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3 A Genome Scale Regulatory Network for Mycobacterium tuberculosis 
3.1 Introduction 
Mycobacterium tuberculosis (Mtb), the causative agent of the disease 
Tuberculosis, is a major worldwide health concern, infecting over 14 million 
people and killing over one million people per year as of 2009[114]. Part of Mtb's 
success as a pathogen has been attributed to its ability to survive in an 
asymptomatic state for months to decades. While the mechanisms that allow for 
the persistence in the host are not completely understood, this is a result of the 
adaptation of the pathogen to the environment of the granuloma[115, 116]. 
Hypoxia produces large-scale changes in the bacterium, one of which is the shift 
to a non-replicating state characterized by drug tolerance. 
One of the main characteristics of latent infection is the formation of 
"foamy" macrophages, characterized by the accumulation of lipid bodies 
consisting of cholesterol, triacylglycerides (TAGs), and phospholipids within the 
cel1[116]. Within these macrophages, the bacteria utilize these lipid bodies as an 
energy source, replicate at a lower rate, and exhibit resistance to multiple 
antibiotic treatments[117]. In essence, the Mtb bacterium facilitates a shift to an 
environment that favors the long-term survival. The regulatory mechanisms that 
govern this response to the host environment are not well characterized, and 
functions for only a handful of the nearly 200 Mtb transcription factors are 
known. Of these, genome-scale binding has only been described for a handful, 
and the interactions between transcription factors required for complex behavior 
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have not been described or studied. 
While there have been few genome-scale studies of transcriptional 
regulation in Mtb, these experiments have relied on indirect measurements such 
as knockout and overexpression microarrays, sequence similarity to other 
organisms such as E. coli[118] and C. glutamicum[119]. Other studies have used 
in vitro methods such as bacterial one hybrid[120, 121]. However, these methods 
are limited as they have been only applied to promoter regions- experiments in 
other organisms have identified a large number of binding sites outside these 
regions[83, 88]. These may yield new insight into the biology of this pathogen. 
This chapter describes the application of ChiP-seq to systematically map 
the binding of the majority of transcription factors of Mtb as part of a larger 
systems-level analysis to integrate transcriptomics, metabolomics, lipidomics, 
and proteomics data to better understand the adaptation of Mtb during the 
transition to and from hypoxia. 
3.2 Systemic Mapping of Transcription Factor Binding Sites 
A tetracycline-inducible system based on the work of Ehrt et al. [122-124] 
was used to episomally express a set of 93 FLAG-tagged transcription factors in 
Mycobacterium tuberculosis. Initially, transcription factors involved in hypoxia and 
lipid metabolism were chosen, using the expression data available in the 
Tuberculosis Database[125], but the set of transcription factors was later extended 
to include those that were expressed in other conditions. The use of an inducible 
promoter to drive transcription factor expression has been used in other 
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systems[126-128]. An inducible system is optimal for this type of analysis, as it 
provides a much higher throughput, since conditions do not need to be 
optimized for each experiment, and the same primary antibody can be used for 
each experiment. This is especially important forM. tuberculosis, as there is very 
little a priori knowledge about the conditions for which many of the transcription 
factors are expressed. 
The immunoprecipitated DNA was sequenced with the lllumina platform, 
and aligned to theM. tuberculosis H37Rv genome[129] using MAQ[130], version 
0.7.1. Coverage along the genome was calculated using the mpileup command 
from the SamTools[89] software suite, version 0.16.1. The ChiP-seq pipeline 
described in Chapter 1 was applied to theM. tuberculosis ChiP-seq data. Enriched 
regions were compared against two wild-type experiments in order to remove 
enriched regions resulting from sequence artifacts. The maximum coverage, 
normalized to the mean coverage for the experiment, in each experiment was 
compared to the normalized coverage in each of the wild-type experiments, and 
those regions that were not at least 5 times higher than wild-type were 
eliminated from further analysis. 
Examination of the remaining enriched regions revealed areas of the 
genome that were enriched in nearly all ChiP-seq experiments. Upon closer 
inspection, many of these regions corresponded to regions shown by ChiP-chip 
to be bound by the histone-like protein Lsr2, which was shown to bind 
nonspecifically to AT-rich regions of the genome to act as a global repressor[131]. 
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In order to remove these artifacts, Lsr2 experiment was used as a second control 
lane, using a cutoff of 2-fold to filter strong Lsr2 binding sites from further 
analysis. The regions remaining after filtering against the wild-type lanes were 
used as the input to the blind deconvolution algorithm for identification of 
binding sites within the regions. 
Potential regulatory events were assigned from peaks using the scheme 
described in Chapter 1. A set of operon predictions for Mtb was used to include 
genes expressed as part of polycistronic mRNAs[132]. If the first gene of an 
operon was found to be bound by a given transcription factor, the rest of the 
genes in the operon were included as potential regulations in the network. A 
total of 180 ChiP-seq experiments were completed, over half of the transcription 
factors of M. tuberculosis. The number of regions ranged from a single binding 
site for a number of transcription factors to 1267 (Rv0967). 
3.3 The ChiP-seq Results Agree With Previously Published Data 
While a variety of transcription factors have been studied by knockout, 
there are three transcription factors in M. tuberculosis whose binding has been 
well characterized at a large scale- DosR, KstR, and EspR. The previously 
published knowledge about the respective regulons of these transcription factors 
was used to evaluate both the peak calling algorithms, as well as the inducible 
system used to perform the ChiP-seq experiments described in this study, as 
shown in the following subsections. 
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3.3.1 DosR 
DosR is one of the most well characterized transcription factors in M. 
tuberculosis. The regulon of DosR has been characterized by knockout[133], 
DNAse footprinting[82], and was the first transcription factor to be analyzed by 
ChiP-seq, using a native antibody under hypoxic conditions. The inducible 
system identified all 47 of the previously characterized regions, and identified 
the binding site at single nucleotide resolution for 44 of the 47 binding events. 
Additionally, we identified a motif similar to the previously identified motif for 
DosR. As shown in Figure 5, the previously identified sites were among the most 
strongly bound in the experiments. 
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Figure 5. Known and novel peaks identified for the transcription factor DosR, and the 
motifs for DosR and KstR. Previously identified peaks are shown in red, while novel 
peaks are shown in blue. The previously characterized motifs for DosR and KstR are 
shown at the top, while the motifs identified by our pipeline are shown at the bottom. 
Note that the motifs identified by our pipeline are somewhat degraded, due to the 
increased number of binding sites used. 
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3.3.2 KstR 
KstR, a transcription factor implicated in cholesterol metabolism, was 
characterized by knockout in Rhodococcus, and later in Mycobacterium smegmatis, 
and a comparative analysis was used to identify putative binding sites in M. 
Tuberculosis. The genomic region containing KstR and many of its targets is well 
conserved between Rhodococcus, M. smegmatis and M. tuberculosis, and has been 
shown to be conserved across many of the organisms related to M. Tuberculosis 
[134}. The ChiP-seq pipeline identifies all27 predicted binding sites. Again, the 
majority of the known binding sites were among the highest peaks, though novel 
binding sites were found with enrichment at or above known peaks. The motif 
identified by our pipeline is similar to the previously identified motif for KstR, as 
shown in Figure 5. 
3.3.3 EspR 
Another transcription factor that has well-characterized regulatory targets 
is EspR (Rv3849). EspR was first identified as a transcription factor which was 
both secreted by the ESX-1 secretion system and a regulator of ESX-1 [135]. 
Molecular characterization showed that EspR is likely able to bridge DNA[136]. 
EspR is the only other "classical" transcription factor in M. tuberculosis other than 
DosR for which ChiP-seq has been performed[136]. In contrast to our 
experiments, the EspR ChiP-seq experiment was performed using an antibody 
native to EspR, without the induction of an episomal factor. Therefore, this 
experiment provided an opportunity to compare the results of our FLAG-tagged 
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system to experiments performed in physiological conditions. The results are 
shown in Figure 6. 
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Figure 6. Comparison of EspR ChiP-seq with published data. A. The motif and class of 
genes identified in each experiment B. While the correlation between the FLAG-tagged 
and native sample are not as high as the native replicates, a strong correlation is still 
observed. C. Regions of enrichment between experiments are very similar in both 
experiments. 
The profile of sequencing coverage in the FLAG-tagged samples is very 
similar to that in the experiments performed with the native antibody. The 
FLAG-tagged experiment recapitulates the previously identified motif, and the 
distribution of the functional classes of the genes in the area of binding sites was 
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similar to the published distribution. Additionally, while the correlation between 
the FLAG-tagged and native experiments (0.76) was not as strong as the two 
native replicates performed by Blasco et al. (0.95), it was still significant (p < lE-
4). Perhaps more importantly, both the native and anti-FLAG antibody identified 
binding sites that were not restricted to the proximal promoter region of genes. 
The authors identify binding sites hundreds of nucleotides away from the 
nearest gene that were shown by atomic force microscopy to engage in long-
range interactions. Finally, another characteristic of the FLAG-tagged 
experiments was identified in EspR - the overlap with regions of Lsr2 
binding[109]. 
3.4 ChiP-seq identifies a large number of sequence-specific binding sites for 
each transcription factor 
As described above, our ChiP-seq experiments identify much greater 
numbers of binding sites for previously characterized transcription factors than 
have previously been described. The observation of a large number of binding 
sites in a previous study of the transcription factor EspR led to the conclusion 
that EspR was likely a nucleoid associated protein. However, this appears to be 
more common than previously thought. Most, but not all, of these novel sites 
exhibit lower coverage in the ChiP-seq experiment than binding sites that have 
been previously identified. Abundant binding of transcription factors has been 
described in a variety of systems, including yeast, worm, fly, and mammalian 
cells, but this is the first observation of this scale in a prokaryote. 
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Enrichment in chromatin immunoprecipitation is a function of the number 
of cells in which a site is bound[83]. In tum, this is governed by the affinity of the 
transcription factor and the concentration of the transcription factor. This was 
confirmed in our experiments by performing ChiP-seq experiments after 
inducing three different transcription factors at O.lng/ ml, lng/ ml, lOng/ ml, and 
lOOng/ml ATe. In these experiments, the highest peaks are bound at lower 
induction levels, while the peaks at the lower end are only identified at the 
highest induction levels. This indicates that the binding observed is due to the 
increased binding of DNA by these transcription factors. This can be seen in 
Figure 7, which shows the titration experiment performed for the transcription 
factor KstR. 
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Figure 7. Titration of KstR induction. As level of induction increases, so does the 
number of binding sites. This indicates that the large number of binding sites is due 
to increased binding by transcription factors, and is not an artifact of the experimental 
system. 
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One potential cause of the large number of binding sites is due to the 
inducible system -were the transcription factors being induced at levels much 
higher than would be seen under physiological conditions? To answer this 
question, the induction of DosR in the inducible system was compared to its 
induction under hypoxic conditions. The induction of DosR at 100ng ATe 
resulted in an expression level of DosR similar to those seen under hypoxia, 
while induction at lower concentrations of ATe resulted in expression at a lower 
level than in hypoxic conditions. Additionally, induction of the DosR regulon 
upon induction of DosR by the inducible system is similar to what is seen under 
hypoxic conditions[137]. 
It is important to note that the peak-calling pipeline identifies an instance 
of a binding motif for each of these binding sites, providing more support that 
these are due to sequence-specific interactions between the transcription factor 
and DNA. As shown in Figure 8, the motif identified from the highest peaks 
tends to strongly resemble the previously identified motif, while the lowest 
peaks tend to bind to a degraded motif (for example, a sequence containing only 
one half of a palindrome). It is important to note, however, that not every single 
instance of the binding site is bound by each of these transcription factors. In fact, 
many strong matches for these binding sites exhibit no evidence of binding at all. 
This may be due to factors such as DNA accessibility, or competition from other 
transcription factors. This is an area for which more research is necessary to 
understand this phenomenon. 
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Figure 8. The binding motif of KstR degrades as the peak height decreases. The blue 
bars show the peak height, while the red bars show the score of the corresponding 
motif, relative to the previously identified motif 
3.5 ChiP-seq in Hypoxia Largely Agrees with Experiments Performed in 
Normoxic Conditions 
Because the ChiP-seq work was being performed in support of modeling 
in order to better understand the behavior of M. tuberculosis from the transition 
to and from hypoxia, a select group of transcription factors (DosR, KstR, Rv0081) 
were chipped under hypoxic conditions. For the vast majority of binding events, 
we see a strong correlation between the strength of binding relative to total 
coverage. While correlated, the correlations between normoxic and hypoxic 
experiments are lower than those between replicates performed under the same 
conditions. This is to be expected, as under different conditions, we expect to see 
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changes which can effect binding strength, such as differential expression of 
cofactors, changes in DNA conformation and accessibility, and post-translational 
modifications of regulatory proteins. However, these results show that the 
inducible system used can identify peaks bound across different conditions, 
producing a more complete map of binding than would be seen in any given 
experiment. 
It should be noted that while we see concordance in relative heights, 
enrichment of coverage for binding sites under hypoxic conditions is generally 
lower than in normoxia. Because the majority of the transcription factors chosen 
for ChiP-seq are themselves induced under hypoxic conditions, this is not 
surprising. In the experimental system used in these experiments, there is both a 
native copy of the transcription factor gene, as well as the FLAG-tagged copy of 
the gene on a plasmid. Therefore, there is competition between the native and 
episomally-coded protein at each binding site. As the concentration of the native 
factor increases, we expect to observe less binding of the FLAG-tagged factor at 
each binding site. This is further suggested by the fact that the background 
coverage is higher in the hypoxic experiments relative to the experiments 
performed in normoxia. Because the number of reads remains constant for each 
condition, a higher percentage of reads will align to the background DNA. 
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Figure 9. Comparison of Hypoxic and Normoxic ChiP-seq. The autobinding peak of 
Rv0081 is a strong outlier (highlighted in red), while the experiment for Rv0494 shows 
strong correlation between experiments. Qualitatively, binding regions have similar 
shapes 
Across the ten transcription factors which have been analyzed by ChiP-
seq in both hypoxic and normoxic conditions, we identify over 4000 binding sites 
across all experiments. Of these binding sites, only a handful show substantial 
differences across conditions (defined in this case as having a least squares 
residual with a Z-score greater or less than 10). These peaks are identified in both 
conditions, though binding is much greater under hypoxic conditions than 
normoxia. Three of these peaks are autobinding peaks found for transcription 
factors that are induced under hypoxic conditions. For all three of these, binding 
affinity appears to increase in hypoxia. This could be due to the binding of 
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another factor that recruits the ChiPped transcription factor, or an increase in 
DNA accessibility in these regions. Representative comparisons of hypoxia and 
normoxia experiments are shown in Figure 9. This provides an area for future 
research, and obviously has implications for the dynamics of the regulatory 
network as Mtb transitions to and from a hypoxic environment. 
3.6 Correlation of Binding with Changes in Expression 
In order to assess the proportion of binding sites that can be associated 
with transcriptional regulation, RNA was harvested from the transcription 
factor-overexpressed samples used for ChiP-seq as described in [138], and 
expression was measured using a Nimblegen microarray consisting of 135,000 
probes spaces at lOObp intervals across theM. tuberculosis genome. Arrays were 
scanned and quantified using a Genepix 400GB scanner with GenePix software, 
version 6.0. RNA preparations and microarrays were prepared in the David 
Sherman laboratory at Seattle Biomedical Research Center. 
The Robust Multichip Average (RMA) algorithm[139, 140] was used to 
normalize the arrays. To compare levels of expression in the TF-overexpressed 
strains to a baseline, the log2 ratio of normalized gene expression in each 
experiment and the corresponding gene in an optical density-matched (OD-
matched) wild-type sample was calculated, This value was used for all analyses. 
From these values, an empirical background distribution was created for each 
gene in the M. tuberculosis genome. The distribution was created using the set of 
overexpression experiments for which the overexpressed transcription factor was 
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not implicated (and thus not expected to have a direct effect on the expression 
level). For each transcription factor identified as a potentially regulator of the 
gene, the expression of the expression value in the cognate microarray was 
compared to the distribution for the gene, to calculate the probability that the 
gene is differentially expressed upon induction of the transcription factor. 
Because, as described above, a given binding site can potentially regulated either 
two or three genes depending on the location, the lowest p-value was chosen as 
the representative for each site. A qFDR calculation[141] was then used to correct 
for multiple testing. A binding site was considered to significantly effect 
expression if its corrected p-value was less than 0.15. 
Additionally, to determine the direction and strength of the potential 
regulation, a Z-score was calculated for each gene across all experiments, 
without taking any of the ChiP-seq information into account. The expression 
values were normalized for each experiment, and the Z-score was calculated for 
each gene across the set of experiments. Genes were considered up- or down-
regulated by a given transcription factor if the Z-score for the gene in the 
overexpression experiment for the respective factor was greater than 1.0 or less 
than -1.0, respectively. 
Looking again at the DosR and KstR experiments, these methods 
identified a potential regulatory effect for 92 and 80 percent of the previously 
identified DosR and KstR targets, respectfully. The results from the Z-score 
calculations agreed with the previously characterized activity of these 
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transcription factors- DosR, an activator, saw the majority of regulatory events 
result in an upregulation of the target, while KstR, a repressor, exhibited the 
opposite behavior. On a larger scale, a regulatory role could be assigned to 43 
and 36 percent of novel DosR And KstR binding sites identified by ChiP-seq, 
respectively. Many (though not all) of these sites exhibit weaker binding than the 
previously published sites, indicating that the resolution of the ChiP-seq system 
is likely greater than the previous methods used to assay the activity of these 
transcription factors. 
3.7 A Regulatory Network of M. tuberculosis 
Through the use of ChiP-seq and expression data, we have built a draft 
regulatory network forM. tuberculosis consisting of roughly half of the known 
and predicted Mtb transcription factors. Consistent with characterized factors in 
Mtb[142, 143] and Corynebacterium glutamicum[144], the majority of these factors 
appear to act as dual regulators, repressing some targets and activating others. 
This regulatory model displays many topological features seen in regulatory 
networks for other organisms. A total of 52 (53%) of the assayed transcription 
factors show autobinding. This is higher than what is observed in E. coli, where 
28% of regulators are observed to regulate their own transcription, with 85% of 
these acting as negative autoregulators[10]. The network contains many 
previously identified network structures, including over one thousand feed 
forward loops (FFLs). Feed forward loops have been shown to introduce a 
variety of dynamic behavior, including pulse generators, sign-sensitive delays 
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and accelerators, and low pass filters[9, 10]. 
3.8 ChiP-seq identifies three regulatory hubs in M. tuberculosis 
Of the transcription factors profiled, three stand out for binding a large 
number of positions on the genome, even after filtering against control lanes. 
These are Rv0965, Rv0081, and KstR (Rv3597c). Rv0081 is part of the initial 
hypoxic response, and is identified in our network as being regulated by DosR 
(as part of the Rv0071-Rv0081 operon). Rv0081 binds in 561 enriched regions 
along the genome, containing a total of 880 binding sites. Using the 
overexpression data, 400 genes are identified as differentially regulated, divided 
roughly evenly between genes that are repressed and activated. These peaks 
were found to significantly (p<1E-12 by the hypergeometric test) overlap regions 
of Lsr2 binding, even taking the Lsr2 filter into account. Lsr2, as described above, 
is a nucleoid-associated protein related to the H-NS protein in E. coli, which has 
also been found to act as a global repressor. Both Rv0081 and Rv3574 target AT-
rich regions of the genome, as can be seen by their respective motifs. 
ChiP-seq identifies another large hub, CsoR (Rv0967), which has been 
shown to bind the largest number of sites of any transcription factor in the 
network. CsoR has been identified as a copper-sensing transcription factor[145] 
that regulates genes involved in copper homeostasis. In contrast to Rv0081 and 
Lsr2, Rv0965 has a motif with high GC content. This is also seen in the E. coli 
ortholog of CsoR, RcnR[146]. Interestingly, RcnR was also shown to bind 
nonspecifically in the area surrounding its binding sites, facilitating DNA 
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wrapping and supercoiling. This is similar to CRP, which was shown to exhibit 
similar behavior, introducing bends in DNA at binding sites. 
3.9 ChiP-seq identifies a regulatory network linking hypoxia to lipid 
metabolism 
As described earlier, one of the major environmental stimuli Mtb 
encounters upon infection is a shift to a hypoxic environment. The binding 
network identified by ChiP-seq contains a subnetwork that links genes known to 
be involved in these two conditions. The cellular response to these two 
conditions has been previously studied in great detail, but these have largely 
been treated as separate systems. The initial response to a hypoxic environment 
is regulated by transcription factors DosR and Rv0081 (itself regulated by DosR). 
A larger stimulon, termed the enduring hypoxic response (EHR)[138], which 
includes some but not all DosR regulon genes, is induced later in the hypoxic 
time course. 
As described above, the transcription factor KstR has been implicated in 
the degradation of cholesterol and lipid metabolism. While KstR was identified 
as part of the EHR, the connection between hypoxia and lipid metabolism had 
yet to be described. ChiP-seq profiling identified four potential regulators for 
KstR. These include Rv0081, Rv0324, Rv1033c, and Rv0023. Of these, Rv0081 is 
the only regulator that is part of the initial hypoxic response apart from DosR, 
and Rv0324 is a regulator associated with the EHR. 
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Additionally, several potential regulators of DosR are identified. These 
include Rv2034, Rv0767c, Rv1033c, Rv0767c, and PhoP (Rv0757). Rv2034 is a 
regulator that was identified as part of the enduring hypoxic response and 
shown in another independent study to regulate DosR[147], thus providing 
positive feedback between the enduring and initial hypoxic response. PhoP has 
also been previously identified as a potential regulator of DosR[148], though 
direct interaction between PhoP and the DosR promoter has not been previously 
described. Other than the autobinding of DosR to its own promoter, the PhoP 
binding site is the strongest amongst the assayed transcription factors. This 
supports the conclusion that the role of PhoP in the adaptation to hypoxia is 
indirect through DosR. PhoP has also been shown to mediate pH adaptation, and 
the network identified by ChiP-seq identify direct regulation of the apr ABC 
locus, a TB-complex specific locus that has been shown to mediate the pH-driven 
adaptation to the macrophage[149]. Finally, PhoP is known to modulate the 
production of virulence lipids. ChiP-seq identifies a binding site upstream of 
WhiB3 (Rv3416), which codes for a redox sensitive protein that has been shown 
to directly regulate the production of these virulence lipids[lSO]. In addition to 
PhoP, the regulatory hubs Rv0081 and Lsr2 are identified to bind upstream of 
WhiB3, with microarray data suggesting that Rv0081 activates the transcription 
of WhiB3. Taken together, these interactions reveal an interconnected 
subnetwork linking adaptation to hypoxia, lipid and cholesterol degradation, 
and lipid biosynthesis. This transcription factor subnetwork is shown in Figure 
10. 
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Figure 10. A Regulatory Subnetwork Linking Hypoxia and Lipid Metabolism. The 
boxes under each gene show the profile of transcription over the Snowglobe time 
course, relative to time 0. Red indicates an increase inexpression, while blue indicates 
a decrease. 
3.10 The Regulatory Network is Predictive of Changes in Mtb during Hypoxia 
and reaeration 
In addition to the ChiP-seq profiling, systems-levellipidomic, proteomic, 
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metabolomic, and transcriptomic profiling was performed over a time course of 
hypoxia andre-aeration. In this model, known as the "snowglobe" model due to 
the appearance of the culture due to the clumping of cells due to the detergent-
free culture. In this model, H37Rv was grown in 7H9 medium, supplemented 
with 0.2% glycerol and 0.05% Tween 80. Cells were cultured for two days in 
aerobic rolling culture. The cells were then transferred into hypoxic conditions, 
where they were sampled after 1, 2, 3, 5, and 7 days of hypoxia. After 7 days, 
they were returned to aerobic conditions, and sampled after 1, 2, 5, and 7 days of 
re-aeration. 
RT-PCR and microarray measurements identify expression changes in 
roughly one third of the Mtb genes over the course of the snowglobe time course. 
Clustering using the DREM algorithm identified Rv0081 as a candidate high-
level regulator. This is consistent with what is seen in the regulatory network 
identified using the ChiP-seq data and overexpression microarrays. ChiP-seq 
identified a large number of binding events in both normoxic and hypoxic 
conditions, while the overexpression of Rv0081 in normoxia alters the expression 
of a large number of genes under normoxic conditions, many of which are 
consistent with the predicted interactions from the ChiP-seq data. 
The regulatory network identified by ChiP-seq is also able to predict some 
of the changes seen in metabolites in Mtb over the hypoxic time course. One of 
these changes is the accumulation of triacylglycerides (TAGs) in hypoxic samples 
as well as sputum samples taken from patients with active TB infections[117, 151, 
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152]. The utilization of TAGs has also been shown to be important for the 
reactivation from dormancy in M. bovis. An increase in TAG accumulation is seen 
during hypoxia, along with a corresponding depletion during reaeration in the 
snowglobe experiments. One scenario that may explain this observation is the 
reduction of metabolites upstream of diacylglyceride (DAG) decrease in 
production, resulting in the conversion of DAG to TAG by triacylglyceride 
synthase. The Mtb genome codes for four triacylglyceride synthases- tgsl 
(Rv3130c), tgs2 (Rv3734c), tgs3 (Rv3234c), and tgs4 (Rv3088). A link between 
hypoxia and the tgs genes has previously been identified, as DosR has been 
shown to induce the expression of tgsl [153]. The ChiP-seq network identifies this 
regulation, along with the potential regulation of tgs2 by Rv0081 and Rv0324, 
two other transcription factors involved in hypoxia. In addition, tgs4 is predicted 
by ChiP-seq to be regulated by DosR and Rv0324. 
Another metabolite important for Mtb infection is methylmalonyl-coA. 
Mtb uses methylmalonyl-coA as a precursor for the synthesis of a variety of 
surface-exposed methyl-branched lipids. These include acylated trehaloses 
(PAT /DAT), sulfolipids (SL), and pthiocerol dimycoserosates (PDIM). PDIM and 
SL have been associated with virulence in murine models[154-157]. During 
hypoxia, expression of genes involved in the synthesis of these compounds is 
generally downregulated. Lipidomics experiments show a modest decline in 
PDIM concentration, while SL-1 precursors and DAT appeared unaltered. 
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During reaeration, an induction of genes coding enzymes in the 
methylmalonyl pathway is observed. This is partially explained by the 
regulatory network. The three subunits of the propionyl-coA carboxylase 
complex (PCC) are regulated by hypoxia regulators: accD4 is regulated by X, 
accDS is regulated by Y, and accD6 is regulated by Z. MutA and mutB are 
predicted to be regulated by KstR and Lsr2. In addition, the membrane 
transporters associated with these lipids are also regulated by TFs involved in 
hypoxia - Mmpl8 is regulated by Rv0081, while MmpllO is predicted to be 
regulated by Rv0324. The regulatory mechanisms associated with methyl-
branched lipid biosynthesis appear to be more complex. PhoP regulates WhiB3 in 
the network, and both of these genes have been shown to regulate the 
production of PAT /DAT (via pks3) and SL (via pks2). The network predicts a 
feed-forward loop involving PhoP and WhiB3, both of which regulate both pks2 
and pks3. 
3.11 Conclusion 
This chapter describes the initial steps in the reconstruction of the 
regulatory network of Mycobacterium tuberculosis, an important human pathogen. 
ChiP-seq accurately identified known regulatory events, as well as predicted 
interactions that were supported by systems-level profiling of proteomics, 
transcriptomics, metabolomics, and lipidomics. While ChiP-seq experiments 
were performed under normoxic conditions, the resulting network was shown to 
be predictive of the behavior of genes over a time course of hypoxia, followed by 
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aeration. This predicted regulatory network is available to the public through the 
Tuberculosis Database, and is expected to serve as a resource to Tuberculosis 
researchers in the future. 
In addition to biological questions for which the network may be used as a 
resource, the ChiP-seq network also identifies a variety of questions about 
transcriptional regulation in prokaryotes for further investigation. As previously 
identified in other studies, this study has identified more binding sites than 
previously expected, even for well studied transcription factors. In addition, 
while binding is enriched for promoter regions, a large number of binding sites 
are found outside of these regions. In fact, some transcription factors appear to 
prefer to bind within genes. This could not necessarily be explained by the use of 
an overexpression system, as some of these transcription factors were expressed 
near physiological levels. Additionally, similar findings have been found for the 
transcription factor EspR, with ChiP-seq experiments performed under 
physiological conditions. Our results suggest regulatory functions for some of 
these sites, although given the large number of sites tested a fraction of those 
predicted to have function are likely false positives. Experiments are ongoing to 
validate predicted functional sites and assess the potential functions of others. 
These findings suggest that the regulation of prokaryotic transcription is 
more complex than previously imagined. This is perhaps not surprising, given 
how once simple regulation of the lac operon has become understood to be more 
complex over the years. This has recently been echoed by reviews on 
50 
transcriptomic studies of prokaryotes[158], where researchers have noted that as 
more research is performed, the complexity of prokaryotic appears to near that of 
eukaryotes[159]. The ChiP-seq network described in this chapter is the most 
complete network for any prokaryotic organism to date, and may serve as a 
resource to better understand the mechanisms underlying prokaryotic 
transcriptional regulatory networks. 
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4 A Regulatory Network Around Light Response and the Clock in 
Neurospora crass a 
4.1 Introduction 
As described in the previous chapter, the ability for an organism to sense 
and respond to a variety of stimuli is essential to ensure its survival. But what if 
some of these stimuli occur on a regular, predictable basis? One such example is 
natural light, as it comes and goes with the rising and the setting of the sun. 
Along with light comes heat, and thus energy, from the sun. In this case, it is in 
the best interest of the organism to be able to prepare for these inputs in advance. 
This has lead to the evolution of internal rhythms, or "clocks" in the regulatory 
schemes of organism. Perhaps the most studied are circadian rhythms, which are 
rhythms that cycle with a period of roughly 24 hours. 
The first description of circadian behavior dates as far back as the 4th 
century BC, though the first experiments showing that these rhythms were not 
dependent on light were not performed not until the 18th century[160]. 
Disruptions in circadian rhythms have been hypothesized to result in a variety of 
disease states, including cancer (reviewed in [161] and [162]) as well as sleep, and 
neurological disorders[163]. One organism that has long-served as a model 
organism for the study of circadian rhythms is Neurospora crassa. 
4.1.1 Neurospora crassa 
Neurospora crassa (Neurospora) is a filamental fungus that has a rich history 
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as a model organism. First identified as the cause of a mold infestation in French 
bakeries in the 1800s, most well-known for its use in the study describing the 
relationship between genes and enzymes[164] that garnered Beadle and Tatum 
the 1958 Nobel prize in Physiology. Neurospora remains an attractive model 
organism because it is easy to grow, has a well-defined sexual cycle, has many 
genetic mutants available, and exhibits many genomic features seen in more 
complex eukaryotes. Some notable features include DNA methylation, light 
response, and circadian rhythms[165]. 
4.1.2 The Circadian Clock in Neurospora 
One of the reasons Neurospora has been used as the basis for a large part of 
the work in the area of circadian rhythms is because its rhythms can be studied 
visually. The production of spores, known as macroconidia or simply conidia, 
occurs daily, peaking before dawn. These conidia are characteristically bright 
orange, due to the hydrophobic carotenoid pigments contained within 
them[166]. This phenomenon was first used to study rhythms in what is known 
as a race tube. A race tube is a glass tube filled with a layer of agar growth media 
on the bottom. A Neurospora culture is inoculated on one end, and the tube is 
transferred into constant darkness. The mycelia grow down the tube at 
approximately constant rate. When conidia are produced, an orange band 
appears along the tube, allowing for the period of the clock to be approximated, 
since distance along the tube corresponds roughly to time[167]. 
By 1980, a variety of Neurospora genetic mutants were discovered that 
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appeared to affect the rhythm of the clock. Among these were mutants for the 
gene frq (frequency), which displayed behavior similar to the per gene in 
Drosophila, another model organism for which the clock was being studied, 
where different alleles resulted in varying period lengths. Indeed, once the frq 
locus was identified and sequenced, it was found to exhibit similarity to the per 
gene[168]. Further study of the FRQ protein showed that the FRQ protein indeed 
fed back on itself, producing the negative feedback required for oscillation. 
As described earlier, one of the characteristics of a circadian clock is that 
the clock can be entrained by environmental stimuli in order to remain in phase 
with the light/ dark cycle of the earth. Indeed, frq was identified to be responsive 
to light[169]. This mechanism allowed the clock to be advanced or delayed 
within the cycle in response to light. The mechanism for this induction was later 
identified as the result of frq regulation by the transcription factors white collar-1 
(wc-1) and white collar-2 (wc-2) through the formation of a "white collar complex" 
(WCC). While these genes were light responsive (wc-1 is a blue light 
photoreceptor[170]), the wee was also found to be essential for the expression of 
frq in the dark, indicating that the wee is a major part of the core of the clock. 
Similar proteins and mechanisms were found in the clocks of other 
organisms[171]. The negative autoregulation by FRQ on frq expression was 
shown to be a result of interaction by FRQ with the wee, causing inactivation 
and a reduction of frq expression. This cycle is governed by the phosphorylation 
of the proteins involved, which has been recently reviewed in detail[166]. 
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As described above, the White Collar Complex is an integral part of the 
Neurospora circadian clock. This chapter describes the analysis of ChiP- and 
RNA-seq data for a subset of the white collar-2 bound transcription factors that 
have been identified. While the mechanism of the central clock has been studied 
in great detail, the downstream circuitry is less fully understood. This chapter 
describes the analysis of ChiP- and RNA-seq for a subset of the WCC-bound 
transcription factors previously identified by ChiP-seq. 
4.2 Identification of Light Responsive Genes by RNA-seq 
As described above, the goal of this project is to better understand the 
interplay between light responsive genes and the circadian clock. The light 
transcriptome of Neurospora has been previously defined using microarrays[172], 
though data was only available for roughly half of the genes coded for by the 
Neurospora genome. As recent studies have shown that RNA-seq can 
complement microarray analysis[173], a study of the light transcriptome was 
performed to extend the set of genes whose transcription was effected by light. 
Two biological replicates of Neurospora were grown in Bird's liquid 
medium for 24 hours, and then induced with light for two hours. Cells were 
harvested at 0, 15, 60, 120, and 240 minutes, capped, and polyadenylated mRNA 
was purified and hexanucleotide priming was used to produced a eDNA library 
for each time point. Sequencing was performed using the lllumina HiSeq 
platform, using single end sequencing. Sequencing reads were aligned to the 
Neurospora genome using Bowtie[174]. An updated annotation, largely 
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including updated positions for the 3' and 5' UTRs (Courtesy of the Broad 
Institute, Not published), was used to guide alignment using the "-G" alignment 
option. RNA extraction and preparation was performed in the Sachs lab at Texas 
A&M University, while sequencing was performed at Oregon Health and 
Science University. 
Differential expression testing relative to the dark time point was 
performed using the cuffdiff program from the Cufflinks suite[175]. Differential 
expression analysis between each of the samples extracted in the light and the 
samples extracted in the dark, as well as FPKM values for both replicates were 
calculated with the cuffdiff algorithm from the Cufflinks suite, version 2.0[175]. 
The Dark, 15, 60, and 120 minute samples showed high reproducibility, while the 
240 minute showed greater amounts of variability in transcript abundance. R2 
values for the log-transformed FPKM values for Dark, 15m, 60m, 120m, and 
240m replicates were 0.95, 0.96, 0.97, 0.96, and 0.75, respectively. 
Of 9728 predicted and validated protein-coding regions, 7660 (79%) were 
identified to have mRNAs covering the transcripts with an FPKM value of 1.0 or 
greater in any given experiment. Of the genes for which are not found to be 
expressed, we see an enrichment for conserved hypothetical proteins. For genes 
with a FPKM less than 1.0, 85 percent are annotated as conserved hypothetical 
proteins, while this number is only 45 percent for genes with a FPKM greater 
than 1.0. Genes with an annotated function but little to no expression were 
enriched for secondary metabolite biosynthesis and sexual development. 
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The levels of many transcripts changed in response to light over the RNA-
seq time course. Analysis of the light transcriptome showed that, independent of 
p-value or q-value, 2354 of the 9728 genes (24%) exhibited a change in transcript 
level of at least 2-fold with respect to the dark grown samples. Of these genes, 
532 (5% of total genes) were significant with a q-value of 0.2. K-means clustering 
was performed using the cummeRbund package from Bioconductor[176]. 
Clustering was performed fork= 2 to 8, and a k of 6 was chosen based on visual 
inspection of the results. The results of the clustering analysis are shown in Figure 
11. 
Four of these clusters represent genes that are induced upon exposure to 
light. Cluster 4 contains genes that are sharply induced at 15 minutes, followed 
by a gradual decline in expression over the rest of the time course. This cluster 
includes many of the genes previously identified to be bound by the wee, 
including vvd, and al-1. Clusters 2 and 6 consist of genes that peak at 60 minutes, 
and decrease in expression over time. This includes other light induced genes 
including.frq and al-2. This cluster includes genes annotated by FunCat to be 
involved in heat and oxidative stress. 
57 
3 
I I I I I I I I I I I I I I I 
DO L15m L60 L120L240 DO L15m L60 L120L240 DO L15m L60 L120L240 
4 5 6 
I I I I I I I I I I 1- I I I I I 
DO L15m L60 L120L240 DO L15m L60 L120L240 DO L15m L60 L120 L240 
variable 
cluster 
- 1 
-2 
-3 
-4 
-5 
- 6 
Figure 11. Clustering of Neurospora light induction microarrays 
Clusters 3 and 5 correspond to genes that are repressed upon exposure to 
light. Both of these show a decrease in expression until 60 minutes, followed by 
an increase in expression from 60 minutes to 240 minutes. While an early 
analysis of Neurospora genes in response to light identified only light induction, 
not repression[172], a contemporary study identified a set of differentially 
expressed genes upon light exposure where only 56 percent of genes were 
induced[7]. This is consistent with the proportion of genes we see, with 54, 58, 58, 
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and 53 percent of genes identified as induced at 15, 60, 120, and 240 minutes of 
light exposure, respectively. This set of light repressed genes is enriched for 
genes involved in ribosomal RNA processing. Ribosomal processing has been 
identified as a process coordinated by the circadian clock in both mammalian 
organisms[177] and Neurospora[7]. Given the ability for light to reset the clock, 
this could be an explanation for a change in expression in these genes. 
4.3 ChiP- and RNA-seq analysis of WCC-bound Transcription Factors 
A previous ChiP-seq analysis of White Collar 2 identified a set of 21 
transcription factors bound by the white collar complex, indicating a possible 
role in the response to light[178]. Because of the role of the white collar complex 
in both light response and the circadian clock, ChiP- and RNA-sequencing were 
performed on a subset of these transcription factors. The data available for each 
of these transcription factors are summarized in Table 1. 
Table 1. WC-2 bound transcription factors. WCC-bound genes that previously were 
not shown to be induced by light are shown in bold. The transcription factors that 
have been analyzed by ChiP-seq are shown in the third column. 
Locus Symbol Light ChiP 
NCU00275 y 
NCU01154 sub-1 y y 
NCU01243 y y 
NCU01871 y 
NCU02094 vad-2 y 
NCU02713 csp-1 y y 
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NCU03184 y 
NCU03273 y 
NCU04179 sah-1 y y 
NCU04295 y 
NCU04731 sah-2 
NCU05964 vos-1 y y 
NCU05994 
NCU06095 csp-2 y y 
NCU07392 adv-1 y 
NCU07728 sre-1 y 
NCU07846 
NCUOSOOO far-1 
NCU08159 y y 
NCU08480 hsf-2 y 
NCU08807 cre-1 y y 
NCU09068 nit-2 y 
NCU09615 y y 
ChiP-seq data was aligned to the Neurospora genome using the Bowtie 
algorithm[174] and binding sites were identified using the pipeline described in 
Chapter 2. A p-value of 0.05 was used for testing for enrichment, while a 
minimum length of lOOnt was used for the length of enriched regions. Regions 
with a shift of less than 60 nucleotides between the forward and reverse strand as 
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calculated by cross-correlation were removed prior to any downstream analysis. 
RNA-seq samples were prepared in the Dunlop lab at Dartmouth College, 
as well as the Sachs and Bell-Pedersen labs at Texas A&M University. RNA-seq 
data was aligned to the Neurospora genome in the same manner as the wild-type 
data, using the annotated transcriptome to guide alignment. The Fragments Per 
Kilobase of exon per Million reads (FPKM) measurement, calculated using 
cufflinks, was used to quantify transcript abundance. FPKM is similar to the 
RPKM (Reads Per Kilobase of exon per Million reads sequenced) measure[179], 
though it takes into account the fact that reads are split as part of the Bowtie 
algorithm in order to map across splice junctions. 
4.4 ChiP-seq Identifies Sequence-specific Binding in Neurospora 
For the peaks identified by ChiP-seq, putative regulatory events were 
assigned based on the location of genomic features relative to binding sites. 
Binding sites were classified as intergenic or genic, and potential regulations were 
classified as upstream, downstream, or in-gene. For the purposes of building a 
potential regulatory map, only upstream and in-gene regulations were considered. 
The number of binding sites identified in each experiment ranges from tens to 
over three thousand. As with the experiments performed in M. tuberculosis, a 
motif instance was identified for each binding site identified by our pipeline. For 
seven of the transcription factors assayed in this study, protein binding 
microarray (PBM) data was made available courtesy of Luis Larrondo. The 
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motifs identified by ChiP-seq are very similar to those identified by the PBM, as 
shown in Figure 12. 
ChiP-seq PBM 
SUB-1 
NCU01243 
NCU02094 
----- :.::.. .. ~ 
CSP-1 
CRE-1 
·L _  c_~n~ ADV-1 
-- ·- ~-·- ·- .. --
·t~~~~ATC~.-Sf WC-2 
~-.. ~- ···· .. ·· · · ·~ -
Figure 12. Comparison of motifs identified by ChiP-seq (left) and PBM (right). For 
each of the transcription factors analyzed by the PBM, ChiP-seq experiments find a 
similar motif. Note that the SUB-1 motif represents only one half of the inverted 
repeat, due to the fact that the protein binding microarray consists of 8-mers 
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Another feature of the Mtb regulatory network that is seen in Neurospora is 
the degradation of the consensus sequence as the peak height decreases. This is 
especially evident for the transcription factor SUB-1, as shown in Figure 13. The 
core SUB-1 motif is by an inverted repeat. The strongest binding sites, largely 
those identified at all three time points, exhibit both halves of the motif, while the 
lower binding sites, largely bound at 15 minutes, when SUB-1 is maximally 
expressed, bind only one half of the motif. SUB-1 was previously identified as a 
potential master regulator of late light responsive genes. A putative consensus 
for SUB-1 was identified by searching differentially expressed genes[172]. 
However, this motif does not match the motif identified by ChiP-seq, indicating 
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1117 1620 1183 
1312 Binding Sites Om 15m 60m 
Figure 13. Degradation of the SUB-1 motif. Peak heights for each experiment are 
shown in the bar plots on the right, while the nucleotide composition around each 
binding site is shown in the heat map. 
4.5 The Regulatory Map of White Collar Regulated Transcription Factors 
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Figure 14 shows the ChiP-seq binding network for Neurospora for both the 
full set of Neurospora genes, as well as the transcription factors. Much like what 
was described in the Mtb regulatory network, we see an interconnected network 
of transcription factors involved in light response, with co-binding of genes by 
many of the white collar-2 bound transcription factors. This high degree of 
interconnectivity has been seen in the analysis of the circadian clock in both 
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mammalian organisms[180], as well as Zebrafish[181]. Additionally, we see 
some of these transcription factors feed back onto the clock- this has been seen 
in a parallel analysis of the transcription factor CSP-1[182], where the repression 
of WC-1 in response to glucose was shown to adjust the period of the clock. 
Figure 14. The Neurospora ChiP-seq network. The network on the left includes all 
genes, while the network on the right shows the connectivity between WC-2 bound 
transcription factors. In the full network, transcription factors are shown in red, while 
their targets are shown in green. 
While core mechanisms of the clock have been well studied, comparatively less 
information is available about the function of the downstream circuitry. The 
network identified by ChiP-seq provides an opportunity to characterize the 
function of these transcription factors. In order to identify a potential regulatory 
role for these transcription factors, The direct targets of each gene were tested for 
functional enrichment using both the Gene Ontology as well as the FunCat[183] 
functional classes. 
Of the transcription factors studied thus far, VOS-1 is found to bind to the 
largest set of genes, with over 15% of the genes in the Neurospora genome 
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identified as potential targets of the transcription factor. GO terms that are 
enriched in the set of targets include those involved in both sexual(G0:0000909) 
and asexual development (G0:0048315). Additionally, a number of genes 
involved in response to osmotic stress are predicted by ChiP to be regulated by 
VOS-1 (G0:0042538 and G0:0006970). The arrival of sunlight is associated with 
hyperosmolarity [184]. VOS-1 is also predicted to regulate a number of genes 
involved in the regulation of the circadian clock and expression of circadian 
genes (G0:0042752 and G0:0032922, respectively). This set of genes includes the 
transcription factor ADV -1, as well as some core components of the circadian 
clock, including WC-1 and FRQ. Genes responsible for the modification of the 
clock proteins are also potential targets of VOS-1, including CKB-1 and FRH, two 
genes that regulate the phosphorylation of FRQ[185, 186]. 
The transcription factor ADV-1, also referred to as Pro-1, is predicted to 
directly bind a set of 843 genes. Enriched top-level functional categories include 
Metabolism, Energy, and Cellular Communication and Signal Transduction 
Mechanisms. GO identifies enrichment for genes involved in the formation of 
conidium (G0:0048315), spore germination (G0:009847), sporocarp development 
involved in sexual reproduction (G0:0000909), hyphal growth and hyphal cell 
wall (G0:0030448 and G0:0030446) as well as light response (G0:0009416). The 
majority of these targets are upregulated upon the knockout of ADV-1, 
suggesting that ADV-1 acts as a repressor. Given that ADV-1 is a target of white 
collar 2, the presence of light induced genes as targets is not surprising. A high-
throughput transcription factor knockout identified the ADV -1 knockout as 
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deficient in both sexual and asexual development, as well as vegetative 
growth[187]. This phenotype is consistent with the targets of ADV-1 by ChiP-
seq. A number of these genes encode for proteins involved in redox reactions. 
Reactive oxygen species have been shown to follow a circadian rhythm in 
Neurospora[188]. A knockout of one of the predicted targets, of ADV-1, NADPH 
Oxidase 1, also showed defects in sexual and asexual reproduction, as well as 
vegetative growth[189]. ADV-1 is also predicted to feed back onto the clock by 
binding to the promoter white collar 1. Binding of the white collar complex has 
also been shown to be mediated by reactive oxygen species, providing another 
mechanism of feedback onto the clock[188]. Additionally, ADV-1 is also 
predicted to feed back onto VOS-1, one of its regulators. 
Other transcription factors were also found to feed back onto the circuitry 
of the circadian clock. As mentioned above, CSP -1 has been shown to feed back 
onto the clock in a glucose-dependent manner[182], compensating for the high 
translation of WC-1 at high glucose levels. Our network identifies the regulation 
of WC-1 by CSP-1, as well as a role in metabolism by FunCat enrichment. We 
observe extensive binding of proteins involved in the core clock circuitry by the 
transcription factors studied in this work. FRQ is bound by NCU01243, SUB-1, 
and CSP-1. WC-1 bound by NCU01243, VOS-1, CSP-2, SUB-1, and ADV-1 in 
addition to CSP-1 as described above. VVD is another blue light photoreceptor 
that has also been shown to work both downstream of and interact with the 
WCC to reset the clock[190, 191]. A number of the transcription factors assayed 
67 
were found to bind upstream or within vvd, including SUB-1, VOS-1, and 
NCU02094. 
Most descriptions and models of the downstream circuitry of the clock 
have referred to a cascade, where early light responsive genes are regulated by 
white collar 1, and temporal resolution is provided by regulation by downstream 
transcription factors in a hierarchical manner[192], and more complex regulation 
has only recently been suggested[182, 193]. The network created from this subset 
of transcription factor suggests that this complex feedback is the norm, rather 
than the exception to the rule. 
4.6 Conclusions 
In this chapter, next-generation sequencing data was used to refine the set 
of light induced and repressed genes in Neurospora crassa, and identify 
downstream genes involved in circadian rhythms and light induction. Our ChiP-
seq pipeline, previously tested on only high coverage data from a smaller 
prokaryotic organism, was applied to data from Neurospora crassa, a fungal 
microbe with a genome roughly an order of magnitude larger than that of 
Mycobacterium tuberculosis. On average, the total sequencing coverage ranged 
from one-third to one-tenth of the coverage in the Mtb ChiP-seq experiments, 
suggesting that the ChiP-seq pipeline is perhaps more generalized than it was 
designed to be. 
An interconnected network of transcription factors involved in light 
response and circadian biology was identified. In addition to the regulation of a 
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number of downstream genes, a number of transcription factors were found to 
feedback onto the core machinery of the clock. While transcriptomics data has 
been collected for both wild type and knockout strains, only a few time points 
after light response are available, largely due to the high cost of microarrays and 
RNA-seq. However, the design of a luciferase reporter assay for Neurospora has 
allowed researchers to study the expression of genes at high temporal 
resolution[194]. This provides a system that will allow the measurement of 
expression at the temporal resolution necessary to better understand the 
dynamics of these tightly interconnected clock-controlled genes and transcription 
factors. 
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5 sRNA Regulation in Mycobacterium tuberculosis 
5.1 Introduction 
Small regulatory RNAs (sRNAs) are another mechanism of regulation at 
the posttranscriptionallevel. These small RNAs work by complementing rnRNA 
to either repress or enhance the transcriptional efficiency. Small RNA can be 
encoded on the genome in two ways. In the first, the small RNA is transcribed 
antisense to a gene coding for a protein on the genome. These are referred to as 
cis-encoded sRNAs, as they act in the same position they are coded. sRNAs may 
also be transcribed in regions of the genome that do not code for any protein. 
These sRNAs then pair with a number of mRNA via imperfect base pairing to 
modulate activity. The possible mechanisms of action of these two classes of 
sRNAs are summarized below. 
Antisense RNA has been identified in all kingdoms of life, though the 
majority have been identified in bacteria[195]. These RNA species were first 
identified in plasmids of E. coli[196], and later discovered to be coded on the 
chromosomes of bacteria. Since then, antisense transcription has been shown to 
be a widespread phenomenon. However, it should be noted that a recent study 
in Bacillus anthracis showed that antisense transcription was enriched on the 
lagging strand, indicating that some of these may arise antisense RNAs due to 
collision between the RNA and DNA polymerases[197]. That said, a number of 
physiologically active small RNAs have been identified, with a variety of 
mechanisms of action. 
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Typically, cis-encoded sRNAs have only a single target, to which they pair 
to with perfect complementarity. However, there have been cases where cis-
encoded RNAs have been shown to potentially regulate multiple orthologous 
targets, including two in Mtb[l98]. These antisense RNAs have been shown to 
regulate their targets by a variety of methods. The canonical mechanism of action 
is the blocking of the Shine-Dalgarno sequence, preventing the ribosome from 
initializing translation[199]. This leads to a lack of translation, and often the 
degradation of both the mRNA and sRNA[200]. Other antisense sRNAs have 
been shown to act by simply catalyzing the degradation of a target mRNA[201, 
202]. Antisense RNA can prevent the transcription of their target genes due to 
polymerase collisions[203] or the formation of terminators upon sRNA 
binding[204]. Finally, these antisense sRNA have been shown to modulate the 
differential translation of genes within polycistronic transcripts by stabilizing or 
catalyzing the processing of the mRNA[205, 206]. These modes of action are 
summarized in Figure 15. 
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Figure 15. Modes of action by cis-acting sRNA. This includes repression by either (A) 
the blocking of a ribosome binding site and mRNA degradation, (B) termination of 
transcription by collision of polymerase, or (C) activation of targets by the 
stabilization and cleavage of polycistronic mNRAs 
In contrast, trans-encoded sRNA can target multiple genes via imperfect 
base pairing. The set of identified mechanisms of action identified for trans-
encoded sRNA are more diverse than those for cis-encoded sRNA. In the 
canonical model of action, the sRNA prevents the initialization of translation, 
either by blocking the ribosome binding site or a standby site[202]. Repression 
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may also occur simply by sRNA-mediated degradation of target mRNA[207]. 
Additionally, small RNAs have been shown to activate the translation of mRNA 
by causing a change in the secondary structure of the mRNA, exposing the 
ribosome binding site to the ribosome[208]. The various modes of regulations by 
trans-acting sRNA are shown in Figure 16. 
Gene 
A 
8 
c 
Blocking Ribosome/ 
Standby Site 
mRNA Degradation 
Alleviation of 
Inhibitory Structure 
Figure 16. Modes of action for trans-acting sRNA. These include (A) blocking of 
ribosome binding either at the RBS or a standby site (B) degradation of mRNA, or (C) 
Alleviation of an inhibitory structure, activating translation of the target 
Small regulatory RNAs have been shown to be important parts of the 
regulatory networks of many pathogens (largely enteropathogens). Some of 
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these sRNAs have been shown to regulate master regulators, including sigma 
factors and nucleoid associated proteins[209, 210]. sRNAs involved in the 
response to different stimuli have been shown to regulate the same factors in 
opposite ways, effectively turning off and on large stress-related regulons[211]. 
Small RNAs have been shown to play a role in the response to acid[205], 
nutrient[212], oxidative[209], temperature and osmotic stresses[210]. In addition, 
sRNAs have been shown to regulate genes involved in the cell membrane[213], 
secretory systems[214], iron homeostasis[200, 215], biofilm formation[216], and 
persistence[217]. 
5.2 Small RNAs in Mycobacterium tuberculosis 
sRNAs were first identified in M. Tuberculosis by Arnvig et al., who used a 
cloning method to identify nine novel sRNA encoded by the genome [198]. Of 
these, four were trans-acting (B11, F5, C8, FF8, and D2), while four were 
identified as antisense cis-acting sRNA (ASpks, ASdes, AS1726, AS1890). C8 was 
later identified as 4.5S housekeeping RNA. Some of these novel RNAs were 
identified as differentially regulated between exponential growth and stationary 
phase, as well as oxidative stress (Bll, B55, F6, ASpks), and acid stress (F6). 
A similar cloning strategy was applied by DiChiara et al. [218], who 
identified a set of 19 noncoding RNA in Mycobacterium bovis BCG, denoted as 
Mcr1-19. Of these, 11 were identified by Northern blot as being expressed in M. 
tuberculosis. Mcr11, which is located between Rv1264 and Rv1265, two genes 
implicated in cAMP metabolism[219], was further characterized. Rv1265 is 
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induced in the macrophage[220] and under hypoxic conditions[221], while 
Rv1264 is induced at low pH[222]. Mcrll was identified as being induced during 
the shift from log-phase growth to stationary phase. This set of sRNAs was then 
extended using a bioinformatic analysis, using the SIPHT sRNA prediction 
tool[223], and filtered using conservation across Mycobacteria to limit false 
positives. Of the candidate sRNAs, 21 (denoted as Mpr1-21) were expressed in 
Mycobacterium bovis. Of these, three were previously identified via the cloning 
strategy (Mpr7, Mpr13, Mpr14), and nine were expressed in M. tuberculosis. The 
majority of the sRNAs identified in this study were novel- Mcr6 was identified 
as the 4.6S RNA, Mcr14/Mpr13 was identified as the sRNA F6, and Mpr19 was 
identified as B11. 
A cloning approach was also utilized to identify putative sRNAs in the 
pathogenic strain M. tuberculosis CDC1551[224]. The authors identified 26 
putative antisense cis-acting sRNAs, and a set of five putative intergenic trans-
acting sRNAs, one of which (ncrMT1302) corresponded to Mcrll from the 
DiChiara et al. study. This sRNA was further characterized experimentally. 
ncrMT1302 was found to be expressed during active infection in a mouse model, 
as well as under low pH. It was also identified to be dependent on the expression 
of the flanking Rv1264 homolog. As was hypothesized by Dichiara et al., 
ncrMT1302 was induced in the presence of cAMP. A binding site for Cmr, a 
transcription factor bound by cAMP, was also identified in the region. 
Finally, there have been three studies utilizing directional RNA-seq for the 
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identification of putative small RNA in M. tuberculosis. The first was performed 
as a part of a larger comparative analysis of Mycobacteria and related organisms. 
The Gumby[225] algorithm was used to identify noncoding regions conserved 
across multiple organisms using a multiple alignment. The EvoFold 
algorithm[226] was used to identify regions which may exhibit a secondary 
structure, and an RNA-seq was utilized to identify putative RNA conserved 
noncoding regions that were also expressed. This study identified 50 novel 
sRNA, four of which were validated by Northern blot analysis. 
Another study utilized total RNA in the cell measured in both exponential 
and stationary phase. The authors compared RPKM on the sense and antisense 
strand to identify putative cis-acting sRNA, and identified intergenic regions 
with high RPKM as locations of putative trans-acting sRNA[227]. The authors 
again showed that sRNAs seem to play an important role during stationary 
phase. One of the most highly expressed sRNAs, MTS2823 was induced roughly 
6.5 fold in stationary phase relative to exponential phase. In order to better 
understand the role of MTS2823, an overexpression experiment was performed. 
While a small number of genes were upregulated upon the overexpression of 
MTS2823, the majority of differentially expressed genes were downregulated. 
These genes showed enrichment for energy metabolism, including a number of 
genes involved in the citrate synthase cycle. Additionally, QT-PCR experiments 
showed that the three highest expressed sRNA accumulate during stationary 
phase, while a control mRNA was shown to decrease in stationary phase. The 
authors also identified another link between cyclic AMP and small RNA in M. 
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tuberculosis- a CRP (cAMP receptor protein) binding site was found upstream of 
the MTS0997, and the expression of MTS0997 was identified as reduced in a CRP 
knockout strain. 
Finally, another pair of studies utilized RNA-sequencing of low molecular 
weight RNA to screen for small RNA in M. Tuberculosis. An initial study utilized 
the sequencing coverage along with sequence conservation across a set of related 
organisms to identify a set of 1948 candidate sRNAs. These were separated into 
three categories. Type A sRNAs were identified as highly expressed in the RNA-
seq experiments. Type B sRNAs were found to have lower expression, but also a 
level of conservation across other Mycobacteria. Finally, type C sRNAs were those 
that were only conserved, and did not show any evidence of expression under 
the conditions studied. A second study[228] further analyzed the type A 
candidates using microarrays, identifying a set of 258 candidate sRNA that were 
expressed in both experiments, twenty of which were further validated by 
Northern blot. The putative targets of the cis-encoded sRNA, defined as the 
genes in which they were encoded, were examined for enrichment. GO terms 
corresponding to membrane proteins and two component systems (which have 
previously been identified as targets of sRNA[229]) were identified as enriched, 
indicating that regulation by cis-acting small RNA might be important in these 
processes. 
All of the trans-encoded sRNA from the initial study[198] were identified, 
while ASdes was the only cis-encoded sRNA identified- all were type A 
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candidates. 17 of the 34 sRNAs identified by DiChiara et al[218], 8 were 
identified as type A candidates, 2 were type B, and 7 were type C candidates. 
While Miotto et al. suggest that the sRNAs which were found to be highly 
expressed in both RNA-seq (type A candidates) and validated by microarray be 
used for further analysis, it is clear that some of the type Band C candidates 
represent small RNAs that were expressed in Mtb. 
These recent studies provide an opportunity to use the M. tuberculosis 
regulatory network described above to better probe the interaction between 
transcription factors and small RNAs. This chapter provides an overview of the 
transcriptional regulation of small RNA in Mycobacterium tuberculosis, and 
describes the potential regulators and roles for some of these small RNA in the 
cell. 
5.3 Assembly of the sRNA dataset 
The small RNAs identified in the studies described above were combined. 
Coordinates identified in [218] and [198]for the small RNA that were expressed 
in Mtb were extracted from Tuberculist[230], and the small RNA for which 
coordinates were mapped (the majority were only described relative to genome 
features) from [227] were extracted from the paper. 
Because the RNA sequences identified in these high throughput studies 
include sequences that code for riboswitches, 5' I 3' UTRs, and other sequences 
that may not be regulatory small RNAs, the sequences were filtered to include 
only those sequences that were antisense to coding regions or located completely 
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within noncoding regions. In addition, the sRNA described in [231] and [228] 
were filtered to include only those sequences that were expressed in both the 
RNA-seq and microarray experiments (defined as having an adjusted p-value of 
less than 0.1). 
Since some of these sRNA were identified in multiple experiments, the 
coordinates were merged using the mergeBed command from the BEDTools suite. 
The resulting small RNAs were then renamed according to a recently described 
naming scheme for Mycobacterial noncoding RNA. Sequences that lie in between 
coding regions are designated as ncRvlX:XXX or ncRVlXX:XX:c, depending on 
their orientation, where :XXXX is the Rv number of the preceding gene. Genes 
that overlap or partially overlap a coding region are denoted as ncRv:XX:XX or 
ncRvX:XXX, where :XXXX is the Rv number of the gene that the sRNA overlaps. 
The final set of noncoding RNA used in the analyses described below are shown 
in Appendix A. 
Finally, the identified and predicted small RNAs were assigned to 
probesets on the microarray design used for the microarrays used for 
transcriptomic profiling of transcription factor overexpression and the hypoxic 
time course. While a number of the previously identified sRNA candidates, 
largely those described in [227], had a corresponding probe set on the 
microarray, the majority were not taken into account in the design. However, 
since the tiling microarrays cover both strands across both coding and intergenic 
regions, probes that overlapped the small RNA could be identified. The 
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sequences for each probe were identified from the microarray design file, and 
aligned to the Mtb genome using version 2.0 of the Bowtie alignment 
algorithm[174]. Probes that were found to overlap a known or predicted small 
RNA were assigned to that sequence. 
5.4 The Expression of trans-acting RNA During Hypoxia and Reaeration 
As described in Chapter 3, we have generated a set of microarray 
measurements over a 14 day time course of hypoxia, followed by a subsequent 
reaeration, known as the "Snowglobe" microarray dataset. Microarray probes 
corresponding to Mtb sRNAs were hierarchically clustered using R to identify 
small RNAs that are induced or repressed during the shift to and from hypoxic 
conditions. Figure 17 shows a heat map of the snowglobe data for the 58 
predicted and validated trans-acting sRNAs described above. 
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Figure 17. trans sRNA over the Hypoxic Time Course. sRNA which are upregulated 
relative to TO are shown in green, while downregulated sRNA are shown in red. 
Columns labeled in red represent time points during hypoxia, while green represent 
time points during reaeration. sRNA which map to multiple microarray probes are 
represented by their name, followed by the probe identifier. Each time point 
corresponds to days in the snowglobe time course 
A large cluster of sRNA is repressed relative to time 0 (the time point 
directly before transfer to the hypoxic environment). The expression of two of 
these, ncRv11610 and ncRv11230c, were strongly repressed upon exposure to 
hypoxia. These sRNA represent RNA7 and RNA2 from the McGuire et al. study, 
respectively. The sequence of these sRNAs was found to be conserved across 
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related actinomycetes, and expressed in an RNA-seq experiment. In addition, 
ncRv11230c was identified by Northern blot analysis (ncRv11610 was not tested). 
Of the genes which exhibit a decrease in expression under hypoxic 
condition, the majority of these return to baseline levels of expression upon 
reaeration. However, a small subcluster of these remains below baseline upon 
reaeration. This cluster includes nvRv13210 (RNA8, identified by conservation 
and RNA-seq), which increases in expression but does not reach the same level 
as at time 0, ncRv10243 (F6), and ncRv11435c (RNA1, with support by 
conservation, RNA-seq, and Northern Blot). F6 is induced upon acid stress[198], 
while the other two have not been profiled in detail. 
A smaller cluster of genes is induced upon a shift to hypoxic conditions. 
Among the small RNAs strongly induced upon a shift to hypoxia include 
ncRv11264c, ncRv13681, ncRv12560, and ncRv2663Ac. ncRv11264c was first 
identified as Mcr11[218], later as MTS0997[227], and finally as ncrMT1302[224]. 
As described earlier in this chapter, this sRNA was shown to be at least partially 
regulated by the cAMP regulator CRP[227]. The expression of ncRv11264c was 
shown to be mediated by pH levels[224]. No further information is known about 
ncRv13681 (originally identified as candidate_1612[228, 231]), ncRv12560 
(mpr11[218]), and nvRv2663Ac (candidate_1456[228, 231]). While not induced to 
the level of these other sRNA, ncRv13661, previously identified as MTS2823[227], 
was also shown to be induced at low levels relative to time 0 during hypoxia. 
One sRNA notably not included in this group is (ncRv1734), previously 
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identified as MTS1338, which was hypothesized to be regulated by DosR[227]. 
This is due to the fact that the clumping caused by the culture conditions causes 
induction of the DosR regulon at T0[232]. The expression of ncRv1734 mirrors 
that of DosR, providing more evidence that ncRv1734 is indeed regulated by 
DosR. These findings suggest that the Snowglobe and transcription factor 
overexpression microarrays may be used to further analyze these novel sRNAs. 
5.5 Identification of Potential Regulators of sRNA by ChiP-seq 
The Mtb ChiP-seq data described in Chapter 2 was used to identify 
potential regulators of Mtb sRNAs. For each sRNA, a window of 300 nucleotides 
upstream and 10 nucleotides downstream of the predicted or annotated 
transcription start site was searched for transcription factor binding sites. The 
search was limited to binding sites with a minimum height of 4 times the median 
coverage in the experiment. Next, the overexpression microarray data was used 
to identify potential binding sites that were supported by expression data. For 
each overexpressed transcription factor, a Z score was calculated across all of the 
features on the microarray. Of the 130 transcription factor-sRNA pairs identified 
by ChiP-seq, 48 (37%) of these have a Z score with an absolute value of at least 1, 
which our experience from the transcription factor-gene network shows is the 
minimum value for which direction of regulation can be reliably predicted. 
While very few regulatory events of sRNAs by transcription factors are 
known, our ChiP-seq experiments identify both previously validated 
regulations. These include the regulation of ncRv1734 by DosR, as well as the 
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regulation of ncRv10243 by the alternative sigma factor SigF. In both cases, 
overexpression of the bound transcription factors results in a large change in 
expression of the microarray probes mapped to the sRNA (Z = 2.8 and Z=4.03 for 
ncRv1734 and nc10243, respectively). This finding confirms that the combination 
of ChiP-seq data and Nimblegen microarrays may be used to identify. sRNA 
regulation by some of the genes in the previously described Mtb subnetwork are 
summarized in Figure 18. 
Table 2. Putative TF-sRNA Interactions with Support from ChiP-seq and Microarray 
Data. Distances are to the start position of the annotated sRNA, while heights are 
normalized to mean coverage. 
TF sRNA Height Distance Position Z Score 
Rv0023 ncRv10867c 20 105 965864 1.3822 
Rv0023 ncRv11075 5 101 1200413 -1.2143 
Rv0081 ncRv11264c 6 116 1413343 3.014 
Rv0081 ncRv3847c 8 258 4322141 2.3507 
Rv0081 ncRv11160 7 55 1287071 1.627 
Rv0081 ncRv0256B 42 38 308900 -1.5813 
Rv0081 ncRv11689c 18 241 1915431 1.5696 
Rv0081 ncRv11075 10 54 1200460 -1.1614 
Rv0135c ncRv1222 4 185 1365089 -1.2584 
Rv0273c ncRv1102A 4 89 1230804 -1.9273 
Rv0324 ncRv11689c 35 149 1915339 2.7115 
Rv0339c ncRv3458 12 57 3878613 -1.7346 
Rv0653c ncRv0256B 34 24 308914 -1.3118 
Rv0757 ncRv11534 29 262 1735431 -2.7121 
Rv0757 ncRv12395 62 53 2692119 -2.3203 
Rv0757 ncRv13778c 25 37 4225003 1.5802 
Rv0967 ncRv11886c 118 126 2136299 -1.2926 
Rv0967 ncRv0243c 4 153 292543 1.0989 
Rv0967 ncRv3458 65 109 3878561 1.0388 
Rv1033c ncRv3809 9 133 4272384 1.2029 
Rv1049 ncRv2241c 10 79 2513804 1.7508 
Rv1049 ncRv13722Bc 7 150 4168564 1.1364 
Rv1353c ncRv3847c 22 53 4321936 -2.0162 
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Rv1353c ncRv0583 5 64 678557 1.4542 
Rv1404 ncRv11374 230 62 1547572 -2.6512 
Rv1423 ncRv2773 4 150 3081544 1.1221 
Rv1675c ncRv1374 4 59 1547070 2.7345 
Rv1816 ncRv13596 9 162 4040717 -1.148 
Rv1990c ncRv1832c 5 76 2078023 1.0826 
Rv2250c ncRv13660c 5 10 4099530 -2.1883 
Rv2250c ncRv3006c 4 209 3365729 -1.3802 
Rv2250c ncRv0824 6 56 918208 -1.3071 
Rv2324 ncRv1205c 5 227 1349184 -1.5779 
Rv2887 ncRv1205c 8 171 1349128 -1.8076 
Rv3133c ncRv1102A 13 138 1230755 -2.9427 
Rv3133c ncRv1734 244 149 1960518 2.8405 
Rv3223c ncRv2706 11 14 3020285 1.6838 
Rv3223c ncRv13596 5 34 4040845 1.0364 
Rv3246c ncRv10867c 69 194 965953 -1.1321 
Rv3249c ncRv2477 11 91 2782904 2.0986 
Rv3249c ncRv0005c 6 78 7333 1.4566 
Rv3249c ncRv13660c 341 38 4099558 1.42 
Rv3249c ncRv11133Ac 5 61 1261585 1.0205 
Rv3574 ncRv1890 4 172 2139247 -1.1401 
Rv3597c ncRv10867c 14 140 965899 -2.6384 
Rv3597c ncRv1374 7 92 1547037 -2.2331 
Rv3597c ncRv1304c 8 89 1460886 -1.0919 
Rv3862c ncRv13778c 5 11 4224977 -2.9266 
Binding sites for PhoP were identified upstream of three putative sRNA. 
These are ncRv11534, ncRv12395, and ncRv13778c. ncRv11534lies directly 
downstream of a Magnesium-sensitive leader sequence- therefore, it may 
simply be part of the 5' UTR of Rv1535. ncRv12395 is located between Rv2395 (A 
membrane protein) and Rv2396 (A PE-PGRS protein). While Rv2396 is a 
potential direct target of PhoP, we do not observe a change in expression upon 
induction (Z = 0.5). Expression of the sRNA, previously identified as Mcr7 and 
confirmed to be expressed by Northern blot[218], is decreased upon induction of 
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PhoP. Rv13778c is located between Rv3778c (An aminotransferase) and Rv3779 
(A conserved membrane protein). Both of these genes appear to be direct targets 
of PhoP, with Z scores of -1.7 and -4.7, respectively. Given this information, one 
assumption may be that this putative small RNA is simply a misannotated 5' 
UTR. However, this sequence was shown to be expressed as a small RNA by 
Northern blot[134]. 
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Figure 18. Transcription factors that regulate sRNA observed to change over the 
hypoxic time course. The expression of the time course for sRNAs that are induced 
(left) and repressed (right) in hypoxia are shown below the time courses. These 
transcription factors have been shown to play a role in hypoxia, cAMP signaling, 
higher-order DNA structure, and adaptation to the macrophage 
The enduring hypoxic response transcription factors are predicted to 
regulate a number of small regulatory RNAs. Rv0324 binds upstream of 
ncRvl1689c, formerly identified as G2[198], and is predicted to induce the 
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expression of the sRNA. This sRNA is located between Rv1689c and Rv1690. The 
expression of these genes does not change upon the induction of Rv0324, 
indicating that the effect of this binding site may be localized to the expression of 
the sRNA. Rv3249c was observed to bind upstream of a number of small RNAs 
which show a change in expression upon Rv3249c induction. These include 
ncRv13660c (B11[198]), which is located between Rv3660c and Rv3661 and is 
induced upon induction of Rv3249c. These genes both show evidence of a 
decrease in expression upon Rv3249c induction (Z = -0.81 and Z=-0.49, 
respectively). In addition, Rv3249c is predicted to regulate two putative cis-acting 
sRNAs. These are ncRv2477, which is antisense to a gene coding for an efflux 
pump induced upon exposure to Oxoflaxin[233], and ncRv0005c, which codes for 
the B subunit of DNA gyrase, the target of quinones, the class of drugs of which 
Oxoflaxin is a member. 
Another potential TF-sRNA regulatory interaction that is supported by 
microarray measurements is the binding of ncRv1374 by the transcription factor 
CMR. Although this peak was relatively low (4 over the mean coverage), and the 
quality of the experiment as a whole was poor, this peak was also seen in a high 
quality ChiP-seq experiment performed in Mycobacterium bovis BCG, where much 
stronger binding was observed (22 over the mean), proving additional evidence 
for this regulation. ncRv1374 was originally identified as MTS1082, and while it 
lies antisense to an annotated open reading frame coding for a conserved 
hypothetical protein, Northern blot analysis identified only the antisense 
transcript, indicating that this is likely a trans-acting sRNA[227]. 
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Most of the transcription factors previously described in the 
hypoxia/lipid subnetwork were found to regulate the earliest identified small 
RNAs in Mtb . This is perhaps not surprising, given that these small RNAs were 
selected due to the fact that they were differentially expressed between 
stationary and exponential phase. Persistence arises during the transition to 
stationary phase[234], and the subnetwork centers around stimuli that are 
important for the adaptation of Mtb to persist in the host environment. 
5.6 Prediction of sRNA targets 
5.6.1 sRNA Target Prediction With TargetRNA 
For each of the putative trans-acting small RNAs, targets were predicted 
using TargetRNA2[235]. TargetRNA operates by searching the region around 
translation start sites of genes for regions that have the potential to base pair with 
the provided sRNA. Additionally, the algorithm takes into account conservation 
and stability of the sRNA- regions of the sRNA which are conserved across 
genomes are considered more likely to interact, and regions of the sRNA that are 
more accessible across the ensemble of predicted secondary structures are 
likewise scored more highly. TargetRNA was chosen due to the fact that the 
algorithm assigns a statistical significance to the base pairing potential, whereas 
other algorithms simply provide the interaction energy. This is calculated by 
comparing the predicted binding energy to a set of 10,000 random sRNA 
sequences. 
Predictions were made with TargetRNA on each of the 59 trans-acting 
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sRNAs using the default parameters- the region around the translation start site 
from 80 basepairs upstream to 20 basepairs downstream was considered, and a p 
value of 0.05 was used as a cutoff for potential interactions. Potential targets were 
predicted for all but one putative sRNA (ncRv11315, corresponding to mcr3 and 
candidate_190 in previous studies). For those sRNAs for which targets were 
predicted, the number of targets ranged from 2 to 44, with a median of 17. The 
number of predicted targets does not appear to correlate with the length of the 
sRNA sequences. 
5.6.2 Network Inference with CLR 
The CLR algorithm[4], which utilizes a compendium of microarray data to 
infer a regulatory network, was used to identify potential sRNA-gene 
interactions. In short, the CLR algorithm utilizes mutual information, along with 
a background correction to identify regulatory links while removing false 
positives caused by regulators or targets that correlate weakly with a large 
number of genes. While the original CLR work focused on the identification of 
transcription factor-gene interactions, a recent analysis in E. coli has extended the 
use of the algorithm to identify potential regulators and targets of trans-encoded 
small RNA[3]. The CLR algorithm was applied to a set of 206 microarrays 
representing the overexpression of 207 transcription factors. Mutual information 
was calculated using the default parameters, corresponding to 10 bins and a 
spline order of 3. CLR scores for each potential sRNA to gene interaction were 
calculated, and an FDR cutoff of 0.005 was used to identify potential interactions. 
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5.6.3 Filtering with Overexpression Microarray data 
Both the T argetRN A inferred network and the CLR network are expected 
to produce false positives. While the CLR algorithm identifies highly significant 
interactions, there is no distinction between indirect and direct interactions. 
Therefore, some of these predicted interactions may be the result of genes being 
co-regulated with the sRNA by one of these transcription factors. Likewise, while 
TargetRNA has been shown to accurately predict sRNA-gene interactions, all 
available sRNA target prediction algorithms have been shown to produce large 
numbers of false positives[236]. 
In an attempt to limit the number of false positives from both of the 
network inference methods, the ChiP-seq data and overexpression microarray 
data was used to filter out sRNA- gene interactions. The level of induction of 
each target predicted for a given sRNA, as measured by Z score, was calculated 
for each transcription factor predicted to regulate the sRNA. The reasoning 
behind this method was that if an sRNA is actively regulating a gene, and a 
transcription factor is regulating that sRNA, we would expect to see a change in 
expression of the target genes for that sRNA. 
While the first filtering step can remove some potential false positives, 
there are other reasons why a change in the expression of a target of a given 
sRNA may be seen upon the induction of a transcription factor predicted to 
regulate it. The simplest case would be that the transcription factor itself 
regulates the target. More complex regulatory cascades could also explain the 
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change in expression of predicted targets upon the induction of the regulating 
transcription factor. The transcription factor that is predicted to regulate the 
small RNA may regulate another transcription factor, which in turn may regulate 
the predicted target of the small RNA. As this is the more likely cause of the 
change in expression rather than the small RNA-mediated regulation, these were 
filtered out as well. 
In order to remove potential interactions that could be explained by the 
regulatory network, a directed graph including transcription factor to gene links, 
transcription factor to sRNA links, and sRNA to gene links was built from the 
ChiP-seq, microarray, and target prediction data. A transcription factor was 
considered to be linked to a gene if it exhibited "direct" binding (defined as 
binding upstream of within the gene), and the absolute value of the Z score for 
the target gene in the cognate overexpression microarray was greater than 1. 
For each sRNA to gene interaction, all paths through the graph from the 
transcription factors that were predicted to regulate the small RNA to the target 
gene were identified. Any predicted sRNA-gene regulations that could be 
explained by a path other than through the sRNA were discarded; these could be 
described through direct regulation by a transcription factor. The remaining 
sRNA-gene interactions were included in the larger model of transcriptional 
regulation. Graph analysis was performed in Python, using the NetworkX 
network analysis library. 
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5.7 An sRNA network for Mycobacterium tuberculosis 
After filtering, we are left with a set of 246 transcription factor-to-sRNA 
and sRNA-to-gene interactions predicted by ChiP-seq, TargetRNA, and CLR. 
The network consisting of transcription factor regulations and sRNA gene 
regulations is shown in Figure 19. It is evident that the transcription factor 
regulatory network filtered out a large proportion of the predicted interactions 
and microarray data - this was expected, due to the large amount of 
interconnectivity in the transcriptional regulatory network. 
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Figure 19. The filtered sRNA-centered network. sRNA are shown in orange, while 
transcription factors are shown in blue. Target genes are shown in grey. 
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Very little is known about the targets of the small RNAs in Mtb. Molecular 
profiling data exists for only one strain in which a small RNA was overexpressed 
-in this case, ncRv13361[227]. Neither our methods, nor a number of other target 
prediction algorithms identified the differentially expressed genes as potential 
targets of ncRv13661. However, there has been a debate on whether it acts via 
traditional base pairing mechanisms, given that the sequence shows homology to 
6S RNA [237], which acts through interaction with the ribosome. The phenotype 
upon sRNA overexpression has been examined for a small number of sRNA as 
well. The overexpression of ncRv13660c resulted in cell death in M. tuberculosis, 
and exhibited reduced growth and elongated cells in M. smegmatis, in which the 
sRNA gene is conserved. The predicted targets from TargetRNA provide a 
potential mechanism for this phenotype - two targets are FtsZ and RodA, two 
proteins involved in cell division. FtsZ is involved in mobilizing the proteins that 
result in the formation of cell wall, and RodA plays a part in the stabilization of 
this complex. FtsZ is essential for in vitro growth in M. tuberculosis, and the 
reduced expression of FtsZ results in elongated cells[238]. The sRNA-mediated 
regulation of FtsZ has been identified in other organisms. One of the advantages 
of sRNA regulation is tight control. In this way, FtsZ is an excellent candidate for 
sRNA mediated regulation- both the underexpression and overexpression of the 
protein have been shown to be detrimental to the cell. The genomic context of 
ncRv13660c also provides support for this Rv3660c is homologous to MinD, 
which plays a role in the destabilization of the complex centered on ftsZ. FtsZ 
has also been shown to be regulated by a small RNA in E. coli, where it is 
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regulated by the DicF small RNA[239]. Additionally, ftsZ expression was shown 
to be reduced under oxidative stress[238], a stress condition under which this 
sRNA has been is induced[198]. This suggests that, while little validation can be 
performed on the predictions in M. tuberculosis given the dearth of available data, 
TargetRNA may provide potential targets that can be experimentally. 
The alternative sigma factor SigH (Rv3223c) has been found to regulate a 
large number of genes involved in the response to oxidative and heat stress[24]. 
SigH is predicted by the network to regulate the small RNA ncRv13596 
(mpr7[218]), which is located between Rv3596c, which codes for an ATP-
dependent Clp protease and the nucleoid associated protein Lsr2. Upon 
induction of SigH, we do not see a change in expression of Rv3596c. We do 
observe a change of expression in Lsr2, even though the binding site for SigH is 
found downstream of the gene. SigH has been associated with a role in the 
modulation of interactions between Mtb and the host[240], though the exact 
mechanisms have not been identified. One of the predicted targets, Rv2223c 
encodes a protein that is exported from the cell, while another, Rv0225, codes for 
a cell membrane protein involved in the synthesis of lipopolysaccharides (LPS), 
which play a part in host-pathogen interactions[241]. Another predicted target of 
ncRv13596 is Rv3536c, which codes for a hydrolase regulated by two 
transcription factors involved in cholesterol utilization, KstR and KstR2[242, 243]. 
This provides another link between hypoxia and cholesterol metabolism in Mtb. 
The only other alternative sigma factor that has been assayed by ChiP-seq 
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in our experiments is SigF (Rv3286c). SigF is involved in the response to 
oxidative stress, heat shock, and acid stress[23], and is induced upon exposure to 
antibiotics. As described earlier, SigF is known to regulate a small RNA, 
nvRv10243c. An analysis of a sigF knockout identified a number of differentially 
expressed cell-wall proteins[244]. Many of the targets of ncRv10243c are 
associated with the cell wall and plasma membrane. The majority of these 
predicted targets are downregulated upon the overexpression of sigF, indicating 
that the sRNA may modulate the sigF-mediated repression of a second set of 
genes involved in stress response, perhaps resulting in the global remodeling of 
the cell wall. This mechanism is employed by the E. coli sigma factor sigE[245]. 
DosR is predicted to regulate two small RNAs in our network. Both of 
these small RNAs, ncRv1102A and ncRv1734, were identified has having targets 
that were not explained by the transcriptional regulatory network. Targets of 
ncRv1734 included another transcription factor, Rv1049, a redox-dependent 
transcription factor[246], one of two transcription factors which have been 
named MosR (the other is Rv0348[247]). MosR has been shown to regulate the 
expression of Rv1050. The expression of Rvl050 is upregulated upon induction 
of DosR. Additionally, a change in expression is seen for many of the targets 
predicted for MosR by the ChiP-seq data upon overexpression of DosR. DosR is 
also identified to regulate treA (Rv2928), which is involved in PDIM synthesis. 
This is consistent with the decline of PDIM during hypoxia and the 
corresponding increase seen in reaeration. 
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A search for enriched metabolic pathways identified the small RNA 
ncRv11160 as a potential regulator of proline biosynthesis. ncRv11160 is 
predicted to repress two genes involved in the proline biosynthesis pathway, 
Rv0500 and Rv2430c. Rv11160 is a predicted target of Rv0081, which is a target 
of DosR. Both Rv2439c and Rv0500 show repression in hypoxia and a 
corresponding induction upon reaeration. As shown in Figure 20, this is 
consistent with other profiling data collected over the hypoxic time course, 
where measurements of proline decrease during hypoxia and increase upon 
reaeration. 
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5.8 Conclusion 
This chapter describes the extension of the Mtb regulatory network to 
include small regulatory RNAs (sRNAs). A set of sRNAs was curated from a 
number of recent publications. The locations of these sRN As were mapped to 
features on a set of microarrays, and a time course of hypoxia followed by 
reaeration was used to identify small RNAs that may be involved in the hypoxic 
response. ChiP-seq and microarray data was used to identify regulation of 
sRNAs by transcription factors, while this data along with network and target 
prediction algorithms were used to identify targets of these sRNAs, many of 
which have functionality consistent with that previously identified for their 
upstream regulators. Some of these sRNA were predicted to regulate other 
transcription factors, providing potential mechanisms for complex circuitry such 
as feed-forward loops. 
It should be noted that the network described in this chapter is in no way 
an exhaustive list of transcription factor-sRNA and sRNA-gene interactions. The 
construction of this network was deliberately conservative, both in the choice of 
small RNAs to study, as well in the choice of filtering methods. Additionally, due 
to the available data, only interactions for which the sRNA modulates mRNA 
levels were detected. While most sRNA are thought to act stoichiometrically, 
there is evidence that this is not always the case in Mtb[227]. Conversely, the 
interactions between small RNA and their predicted targets will need to be 
validated experimentally. While microarray-based methods, measuring changes 
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in expression from either knockouts or overexpression of an sRNA, have been 
used in the past to identify sRNA targets, these again can only identify targets for 
which expression changes. Another possibility is the use of proteomics data. 
Other methods for sRNA target identification and validation, including 
immunoprecipitation and GFP fusion reporter systems have been reviewed 
extensively[248], and could be used to identify and validate targets of these 
sRNAs. 
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6 Discussion 
6.1 Conclusions 
This work describes the development of a pipeline for the analysis of high 
coverage ChiP-seq data, and the application of this pipeline to the regulatory 
network construction of two organisms, Mycobacterium tuberculosis and 
Neurospora crassa. The ChiP-seq data was combined with other -omics data, 
including transcriptomics, proteomics, and metabolomics, to map the regulatory 
networks of these organisms. 
The Mycobacterium tuberculosis transcriptional regulatory network is the 
first reconstruction of a regulatory network of its scale in a prokaryote. This 
reconstruction was the result of a coordinated effort across multiple labs, 
integrating data from multiple platforms to better understand the hypoxic 
response. An inducible promoter system was used to overexpress over half of the 
Mtb transcription factors, and the ChiP-seq pipeline was used to identify binding 
sites for these transcription factors. In addition to known sites for previously 
profiled transcription factors, many novel binding sites were identified, some of 
which were supported by evidence in transcriptome data from the samples used 
for ChiP-seq. The resulting regulatory network showed a link between hypoxia 
and lipid metabolism, two important roles, and links in this network were 
supported by metabolomics and lipidomics data. 
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6.2 Future Directions 
Given the scale of these experiments, it is clear that the conclusions to be 
made from these network reconstructions are far outside the scope of a single 
thesis. While these regulatory network reconstructions have helped better the 
understanding of their respective organisms, they also open many doors for 
future research, both into the underlying biology of these organisms as well as 
the nature of transcriptional regulation itself. One of the obvious avenues that we 
expect to be performed by researchers in these communities is the validation of 
interactions predicted by ChiP-seq. In fact, we have already seen validation of 
some of these links by researchers who have used data made available through 
the Tuberculosis Database[147]. Additionally, as the regulatory network is 
completed, methods like in vivo protein occupancy display (IPOD)[249] can be 
used to identify changes in binding across different conditions, supplementing 
the current condition-independent network. 
Neurospora has a long history of use as a model organism, though systems-
level analysis has largely been performed on other organisms. While initial steps 
have been made to create a Neurospora regulatory network, the network 
described in this work is much sparser than the Mtb regulatory network. An 
obvious step forward is to continue the reconstruction of this network. 
Additionally, this network can be combined with histone modification ChiP-seq 
data to better understand the effect of these modifications on large-scale changes 
in expression. In contrast to the Mtb regulatory network reconstruction, the 
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Neurospora experiments were performed with chromosomally tagged 
transcription factors, choosing a time point for ChiP-seq based on protein levels 
over the light time course. A light-inducible system has been developed to allow 
for the control of Neurospora genes[250]- this system could be used to perform 
experiments at higher throughput than the current experiments, even for 
transcription factors which are not induced by light. 
As they have been researched, small RNAs have been found to play an 
increasingly pivotal role in the regulatory network of prokaryotes. While this 
study used existing data to include small regulatory RNAs in the regulatory 
network, future systems-level studies should take these into account during 
study design. In studies taking a similar approach to the Mtb reconstruction, 
immunoprecipitation can be performed on well-characterized sRNA, and targets 
can be identified. RIP-seq can also be used to assay RNA-binding proteins, which 
may also be targets of these small RNAs. 
I consider this work to be the start of two larger overall research threads. 
First, the network can be continued to probe the mechanisms of infection of 
Mycobacterium tuberculosis. Secondly, the ChiP-seq and microarray data can be 
used to better understand the nature of transcription in general. I look forward to 
seeing the research enabled by these tools, and hope to continue my work in this 
area. One area where I believe more work is necessary going forward to grow the 
field of Systems Biology is in the design of user-friendly tools for systems 
biology. While there has been great work in the development of visualization 
101 
tools such as Cytoscape and GenomeView[252], and workflow tools such as 
Galaxy and Kepler, these are largely designed for use both by and for 
computational biologists. As sequencing becomes cheaper and more researchers 
look to ChiP- and RNA-seq to apply to their organisms or systems of interest, 
there will be a need for tools for scientists who may not have much experience 
with conversion between file formats, scripting, and database design and use -
tasks performed daily over the course of the work described in this work. Ideally, 
these tools would be built on top of existing platforms. Whether this would be a 
generalized tool for biological data storage and analysis such as LabKey[253], 
organism-specific databases such as TBDB[l25, 254], or general bioinformatics 
portals such as PATRIC is a matter of debate. As the field moves forward, the 
development of such tools would increase adoption of new algorithms and 
procedures, and result in the faster reconstruction of regulatory networks and 
other genome-scale resources. 
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Appendix A. 
Predicted and identified cis- and trans- acting sRNA in Mycobacterium tuberculosis 
ncRNA Start Stop Strand Type Other Names 
ncRv0005c 7201 7255 - cis candidate 898 
ncRv0020 24672 24787 + ClS candidate 3 
ncRv0046 50563 51056 + cis candidate 5 
ncRv0061c 65234 65389 cis candidate 908 
ncRv0076 85206 85276 + ClS candidate 12 
ncRvOlOlc 110447 110563 - cis candidate 919 
ncRv0157c 185055 185087 cis candidate 927 
ncRv0188c 219653 219782 cis candidate 945 
ncRv0243c 292336 292390 - cis candidate 956 
ncRv0256A 307966 308037 + ClS candidate 35 
ncRv0256B 308938 309021 + ClS candidate 3 7 
ncRv0284c 345820 345941 - cis candidate 970 
ncRv0412 498401 498455 + cis candidate 54 
ncRv0451 541778 541817 + cis candidate 66 
ncRv0483Ac 572607 572654 - ClS candidate 1003 
ncRv0483Bc 572685 572737 - cis candidate 1 004 
ncRv0485 575033 575069 + ClS mcr19 
ncRv0490c 580526 580568 - cis candidate 1 007 
ncRv0497c 587585 587733 - cis candidate 1008 
ncRv0539c 631900 631940 - cis candidate 10 18 
ncRv0583 678621 678785 + cis candidate 82 
ncRv0611 706101 706243 + cis candidate 85 
ncRv0636c 732392 732787 - ClS candidate 1029 
ncRv0778c 872009 872104 - ClS candidate 1 064 
ncRv0824 918264 918458 + cis ASdes 
ncRv0931A 1038819 1038867 + ClS candidate 132 
ncRv0931B 1039633 1039677 + CIS candidate 133 
ncRv0932 1040645 1040938 + cis candidate 13 5 
ncRv0983c 1099540 1099583 - cis candidate 1112 
ncRv1013c 1132075 1132182 - cis candidate 1121 
ncRv10243 293604 293705 + trans F6 
ncRv1028 1149692 1149736 + trans candidate 143 
ncRv10349c 419704 419750 - trans candidate 984 
ncRv10403 483829 483878 + trans RNA4 
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ncRv10567 659351 659390 + trans RNA10 
ncRv10609 704187 704247 + trans candidate 84;B55 
ncRv1081c 1205849 1205992 - trans SCortho2 
ncRv10867c 965725 965759 - trans candidate 1 083 
ncRv1087c 1212564 1212615 cis candidate 1130 
ncRv10887 987053 987145 + trans RNA6 
ncRv10932c 1041129 1041165 - trans candidate 1096 
ncRv1102A 1230893 1231069 + trans candidate 153 
ncRv11051 1175225 1175315 + trans mpr5 
ncRv11075 1200514 1200607 + trans RNA5;candidate_ 149 
ncRv11092c 1220388 1220487 - trans MTS0858 
ncRv11133Ac 1261487 1261524 - trans candidate 1133 
ncRvlll33Bc 1261558 1261601 - trans candidate 1134 
ncRv11155c 1282030 1282128 - trans candidate 1139 
ncRv11160 1287126 1287201 + trans candidate 161 
ncRv11230c 1374224 1374270 - trans RNA2 
ncRv11248c 1393055 1393140 - trans RNA3 
ncRv11264c 1413094 1413227 - trans MTS0997;mcr11 
ncRv11315 1471619 1471742 + trans mcr3;candidate _190 
ncRv11315c 1473967 1474360 - trans candidate 1188 
ncRv11374 1547634 1547677 + trans candidate 204 
ncRv11435c 1612987 1613045 - trans RNA1 
ncRv11534 1735693 1735747 + trans candidate 224 
ncRv1157 1283693 1283815 + cis mcrlO 
ncRv11610 1810184 1810228 + trans RNA7 
ncRv116lc 1290289 1290381 - ClS candidate 1141 
ncRv11689c 1914962 1915190 - trans G2 
ncRv1173c 1303572 1303742 - cis candidate 114 7 
ncRv11765 1999540 1999585 + trans candidate 252 
ncRv11886c 2136126 2136173 - trans candidate 1314 
ncRv1196c 1340450 1340508 - ClS candidate 1158 
ncRv1205c 1348918 1348957 - ClS candidate 1161 
ncRv12185c 2447526 2447600 - trans RNA12 
ncRv1222 1365274 1365365 + trans mpr6 
ncRv1233A 1376548 1376592 + cis candidate 182 
ncRv1233B 1376687 1376720 + cis candidate 183 
ncRv12395 2692172 2692521 + trans mcr7;candidate_350 
ncRv1248 1392354 1392391 + ClS candidate 184 
ncRv12560 2881252 2881320 + trans mpr11 
ncRv12562 2882185 2882276 + trans mpr12 
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ncRv1270 1419609 1419653 + cis candidate 186 
ncRv1283 1436445 1436486 + cis candidate 187 
ncRv1286c 1439891 1440077 cis candidate 11 71 
ncRv12929 3243367 3243516 + trans candidate 432 
ncRv13001c 3360598 3360620 - trans SCorthol 
ncRv1304c 1460757 1460797 cis candidate 1176 
ncRv13210 3587635 3587691 + trans RNA8 
ncRv1323c 1486759 1486919 cis candidate 1198 
ncRv13260Ac 3640142 3640237 - trans SCortho5 
ncRv13260Bc 3640277 3640344 - trans candidate 1543 
ncRv13415c 3834785 3834889 - trans SCortho4 
ncRv13476 3893960 3894002 + trans candidate 526 
ncRv13596 4040879 4040938 + trans mpr17 
ncRv1364c 1535417 1535716 - trans mcr15 
ncRv13651 4093468 4093522 + trans mpr18 
ncRv13660c 4099379 4099520 - trans SCortho3 ;candidate_ 1603;B11 
ncRv13661 4100669 4100977 + trans MTS2823 ;candidate_ 561 ;candidate_ 562 
ncRv13681c 4121675 4121713 - trans candidate 1612 
ncRv13722Ac 4168154 4168281 - trans C8 
ncRv13722Bc 4168345 4168414 - trans candidate 1622 
ncRv1374 1547129 1547268 + cis MTS1082 
ncRv13778c 4224925 4224966 - trans RNA9 
ncRv13843c 4317073 4317165 - trans MTS2977 
ncRv13859c 4336194 4336309 - trans candidate 1649 
ncRv1428 1603966 1604006 + cis candidate 209 
ncRv1583 1786244 1786276 + cis candidate 228 
ncRv1594 1794708 1794756 + trans RNA11 
ncRv1595c 1797023 1797120 cis candidate 1246 
ncRv1609c 1809246 1809291 - cis candidate 1250 
ncRv1629c 1830727 1830905 - CIS candidate 1255 
ncRv1640 1851991 1852022 + cis candidate 23 7 
ncRv1651 1864044 1864146 + cis candidate 241 
ncRv1726c 1952291 1952503 cis ASRv1726 
ncRv1734 1960667 1960783 + trans MTS1338 
ncRv1784Ac 2023361 2023447 - trans candidate 1285 
ncRv1831 2075588 2075769 + cis SCortho6 
ncRv1832c 2077860 2077947 cis candidate 1309 
ncRv1863 2111229 2111274 + cis candidate 270 
ncRv1887c 2137034 2137087 cis candidate 13 1 7 
ncRv1890 2139419 2139656 + cis AsRv1890 
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ncRv1980 2223680 2223955 + CIS candidate 280 
ncRv2006c 2253965 2254133 cis candidate 1337 
ncRv2048 2299745 2299886 + cis ASpks12 
ncRv2080c 2337642 2337778 cis candidate 1348 
ncRv2082c 2340717 2340752 cis candidate 13 52 
ncRv2114c 2374202 2374380 - cis candidate 1354 
ncRv2115 2376084 2376123 + cis candidate 309 
ncRv2127Ac 2390078 2390135 - trans candidate 1355 
ncRv2130 2392027 2392089 + CIS candidate 310 
ncRv2137 2397263 2397308 + cis candidate 312 
ncRv2175c 2437823 2437866 - cis mcr5 
ncRv2180 2442962 2443046 + cis candidate 31 7 
ncRv2225c 2498149 2498371 cis candidate 1392 
ncRv2241c 2513682 2513725 - cis candidate 1396 
ncRv2243c 2517032 2517134 - cis mcr16 
ncRv2312c 2584567 2584633 - cis candidate 1407 
ncRv2477 2782995 2783031 + cis candidate 374 
ncRv2519c 2837089 2837249 cis candidate 1438 
ncRv2525 2850140 2850171 + cis candidate 383 
ncRv2586 2913406 2913524 + cis candidate 389 
ncRv2657 2979204 2979244 + cis candidate 406 
ncRv2663Ac 2981852 2982087 - trans candidate 1456 
ncRv2706 3020299 3020346 + cis candidate 413 
ncRv2711c 3023904 3024065 cis candidate 1460 
ncRv2773 3081694 3081748 + cis candidate 417 
ncRv2933c 3258294 3258348 - cis candidate 14 77 
ncRv2940 3281621 3281692 + cis candidate 433 
ncRv2942c 3286205 3286244 - cis candidate 1487 
ncRv2950c 3302436 3302477 - trans candidate 1489 
ncRv2956c 3308995 3309145 - CIS candidate 1490 
ncRv3006c 3365470 3365520 - cis candidate 1503 
ncRv3009 3368476 3368529 + cis candidate 453 
ncRv3128 3493181 3493288 + cis candidate 469 
ncRv3130 3495616 3495675 + cis candidate 4 70 
ncRv3277c 3660060 3660144 - cis candidate 1548 
ncRv3388c 3802776 3802840 - cis candidate 1557 
ncRv3429c 3847544 3847639 - cis candidate 1567 
ncRv3458 3878670 3878794 + cis candidate 521 
ncRv3477c 3894219 3894262 cis candidate 1575 
ncRv3484c 3903230 3903275 - cis candidate 1577 
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ncRv3519c 3955608 3955646 - cis candidate 1585 
ncRv3521c 3957603 3957646 - cis candidate 1589 
ncRv3645c 4082867 4083070 - cis candidate 1600 
ncRv3667Ac 4108495 4108590 - CIS candidate 1606 
ncRv3667Bc 4109595 4109633 - CIS candidate 1608 
ncRv3675c 4116278 4116321 - cis candidate 1609 
ncRv3684c 4125745 4125797 - CIS candidate 1614 
ncRv3809 4272517 4272644 + cis candidate 580 
ncRv3842 4314799 4315001 + cis candidate 586 
ncRv3847c 4321846 4321883 - CIS candidate 1648 
ncRv3876c 4354387 4354477 - cis candidate 1657 
ncRv3914c 4402676 4402800 - cis candidate 1666 
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